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INTRODUCTION 
The vitamin-B5 containing coenzyme pyridoxal 
5'-phosphate (PLP) is required by many enzymes as a tool to 
catalyze reactions involving compounds which are otherwise 
stable within the cell. Enzymes depending upon this 
coenzyme catalyze a wide range of metabolically important 
reactions most of which involve amino acids and nitrogen 
metabolism. PLP is a reactive molecule containing three 
important functional groups and a phosphate 'handle' (Fig. 
1). The maximum absorbance of light by PLP is at a 
wavelength different from that of proteins. Changes in this 
absorbance while the protein 'machinery' is working allow 
PLP to be used as a 'reporter' group. Increased 
understanding of the biological processes that depend upon 
vitamin B5 may be of practical importance for the 
optimization of these processes. It may be essential for 
better nitrogen utilization and increased agricultural 
productivity. This information may also be useful 
medically. For example, an attempt has been made to control 
an aspect of Huntington's disease. The depressed 
concentration of a neurotransmitter (gamma aminobutyric 
acid) was raised by specifically inhibiting the vitamin B6 
dependent enzyme which degrades it. Although the 
concentration did increase, the disease was not controlled 
(Tell et al., 1981). 
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The studies described here involve a single enzyme, 
aspartate aminotransferase. However, interactions between 
the protein, substrate, and coenzyme, which are important 
for catalysis, may be similar for a large group of PLP-
dependent enzymes with similar construction and operation. 
Therefore, the results described may be of general 
importance. 
The transfer of an amino group from one carbon skeleton 
to another is an essential reaction catalyzed by PLP-
dependent enzymes called aminotransferases or transaminases. 
The structure of aspartate aminotransferase (EC 2.6.1.1), 
abbreviated AAT here, has been determined to 2.4 angstrom 
resolution (Arnone et al., 1985) and changes in the 
structure during catalysis have been observed. The 
properties of this much studied enzyme may now be related to 
a molecular model (Fig. 2). Thus, AAT is a good choice of 
an enzyme for this study. 
The study of analogs of PLP has also contributed to our 
understanding of catalysis (Metzler and Fonda, 1985). 
Analogs of the coenzyme interact with enzymes in ways that 
are dependent upon properties of both the enzyme and the 
altered coenzyme. The interactions of two coenzyme analogs 
in aspartate aminotransferase are described in this 
dissertation. The first, 6-fluoropyridoxal 5'-phosphate 
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(6-FPLP), was studied using both ultraviolet-visible and 
NMR spectroscopy. Both the chemical shift and bandwidth of 
the NMR signal have been recorded for the free compound, 
its Schiff base with valine and related compounds at various 
pH values. The ^'F NMR spectrum is a sensitive monitor of 
the state of protonation of both the pyridinium nitrogen and 
the 3-hydroxy1 group. Sensitivity to the state of 
protonation of the pyridinium nitrogen in the enzyme-bound 
coenzyme may make this a useful probe for many enzyme 
systems. Study of ^®F NMR spectra of enzyme-bound 6-FPLP 
complements UV-visible spectroscopy which is not sensitive 
to the state of protonation of the ring nitrogen in Schiff 
bases. Rate constants involving interactions with 
substrates and inhibitors may also be obtained. The purpose 
of obtaining this information is to figure out how a protein 
(AAT) works at the molecular level. The ^'F resonance can 
be correlated with both the UV spectrum and the crystal 
structure. 
The second analog, pyridoxal 5'-sulfate (PLS), 
covalently modifies apo-aspartate aminotransferase producing 
a fluorescent chromophore (Yang et al., 1974). This 
chromophore was isolated as a tripeptide containing a 
modified lysine residue by Schmidt et al. (1982). The 
characterization and synthesis of this modified lysine is 
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described in this dissertation. Related compounds 
containing the same chromophore have been synthesized from 
pyridoxal sulfate and simple alkyl amines. This is a new 
synthetic route to the pyrrolopyridine ring structure. 
Products resulting from reaction of these substances with 
base and sodium borohydride have also been characterized as 
has a similar fluorescent chromophore derived from the 
5*-trans-carboxyethenyl analog of PLP. 
Pyridoxal 5'-Phosphate (FLP) 6-Fluoropyrldoxal 5'-Phosphate (6-rPLP) 
5'-trans-Carboxvethyenyl Analog of PLP Pyridoxal 5'-Sulfate (PIS) 
FIGURE 1. Vitamin B6 and the coenzyme analogs used in this 
study 
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FIGURE 2. Active site of AAT Top: stereo drawing courtesy 
of Craig Hyde. Bottom: Schematic drawing 
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LITERATURE REVIEW 
PLP, a derivative of vitamin B6, is a coenzyme 
necessary for the catalytic activity of many different 
enzymes (Braunstein, 1970). Enzymes use PLP as a tool to 
catalyze reactions millions of times faster and with greater 
specificity than can be obtained without the enzyme. 
Vitamin B6 was identified and synthesized in 1939 (Stiller 
et al., 1939; Kuhn and Wendt, 1939). A role in 
transamination was proposed by Snell (1944) who suggested a 
'ping pong' mechanism. The basic mechanism of catalysis by 
PLP in transamination and other reactions was proposed by 
Braunstein and Shemyakin (1952, 1953) and independently from 
non-enzymatic studies by Metzler et al. (1954). 
An enzyme can facilitate a reaction through correct 
initial orientation of the substrate followed by sequential 
changes both in the electronic distribution and in the 
geometry of the substrate complex (Fig 3). In the case of 
PLP-dependent enzymes, the coenzyme combines with the 
substrate amino group and then acts as an 'electron sink' 
which can reversibly withdraw an electron pair from the 
substrate to the protonated pyridinium nitrogen of the 
coenzyme (Fig 3, step 5). This facilitates bond breaking 
and making in the substrate. 
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AAT catalyzes a reversible transamination reaction in 
which the nitrogen of aspartate is removed yielding 
oxaloacetate and is then given to 2-oxoglutarate to form 
glutamate. The enzyme is used by the cell to direct the 
flow of carbon into and out of the tricarboxylic cycle, 
nitrogen into urea, and of reducing equivalents into the 
mitochondria (Cooper and Meister, 1985). The level of this 
enzyme in the blood serum has been utilized clinically to 
assess tissue damage (Schmidt and Schmidt, 1985). 
There are two isozymes of aspartate aminotransferase, 
cytosolic and mitochondrial. The cytosolic isozyme was 
first isolated from pig hearts by Jenkins in 1959. The 
ability to isolate large amounts of a stable relatively pure 
enzyme as well as the presence of PLP at the active site has 
stimulated numerous investigations of catalytic properties 
of this enzyme. These are reviewed by Braunstein (1973), 
Martinez-Carrion (1975) and Christen and Metzler (1985). 
The sequence of the 412 amino acids in pig heart 
cytosolic AAT was determined by Ovchinnikov et al. (1973) 
and independently by Doonan et al. (1975). Crystals 
suitable for high resolution X-ray analysis were obtained by 
Arnone et al. (1977). The structures of chicken heart 
cytosolic (Borisov et al., 1977; Borisov et al., 1985) and 
mitochondrial (Gehring et al., 1977; Jansonius et al., 1985) 
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isozymes have also been determined and are similar to that 
of the pig heart cytosolic enzyme (Christen et al., 1985). 
The dimeric enzyme's active sites are at the bottom of 
a 15 A deep pocket formed between the two subunits. Binding 
of the alpha and distal carboxyl groups of the substrate 
(Fig 3) to Arg 292 and Arg 386 respectively induces a 
conformational change. This closes the pocket by moving a 
small domain which forms one side. The movement increases 
the reactivity of Cys 390 to sulfhydryl reagents as reported 
by Birchmeier and Christen (1971). Variations in peptide 
proton exchange (Pfister et al., 1978) and changes in 
NMR linewidth of trifluoroacetate (Critz and Martinez-
Carrion, 1977) can also be attributed to this conformational 
change. Attachment of the epsilon amino group of Lys 258 to 
the PLP ring as an 'internal' aldimine was demonstrated by 
sodium borohydride reduction, proteolytic digestion, and 
isolation of the reduced chromophore attached to Lys 258 
(Hughes et al., 1962). 
Ivanov and Karpeisky (1969) proposed that 
neutralization of a positive group (Arg 385) would release 
the negative charge on the phenolate oxygen (Fig 3, step 1). 
This should raise the pK of the imine nitrogen (donated by 
the epsilon amino group of Lys 258) and lower the pK of the 
substrate amino group, facilitating the transfer of a proton 
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from the substrate amino group to the imine group. Lysine 
258 is also in a position to deprotonate the substrate alpha 
carbon to form the quinonoid intermediate (Fig 3, step 5) as 
proposed by Wada and Snell (1962), Ayling et al. (1958) and 
Ivanov and Karpeisky (1969). Charged groups in the enzyme 
may interact with the 3 *-hydroxyl or pyridinium nitrogen at 
the appropriate time. Ivanov and Karpeisky (1969) suggested 
that each step in enzymatic catalysis sets up the next step; 
for example, at each stage functional groups may be 
protonated in such a way as to facilitate the next step. 
The pyridinium nitrogen of the coenzyme forms a tight 
hydrogen bond with Asp 222. This bond may be weakened upon 
binding of the substrate analog 2-methylasparate, allowing 
the coenzyme ring to rotate 20° (Fig 3, step 3a) around 
either the C5'-05" bond or the C5-C5' and 05"-phosphate 
bonds (Arnone et al., 1985). 
The apparent pK of the coenzyme of native enzyme is 
strongly dependent upon the anion concentration (Boyde, 
1958; Bergami et al., 1958; Giannini et al., 1976; Jenkins 
and Fonda, 1985), shifting from a low of 5.4 at low ion 
concentrations (Braunstein, 1973) to about 6.8 in solutions 
with high concentrations of certain anions. Anions bind to 
AAT and compete with substrates. Jenkins (1980) estimated a 
dissociation constant of 21 mM for CI" at low pH 
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spectrophotometrically. Arg 386 and 292 are the most likely 
anion binding sites. Deprotonation of the Schiff base imine 
nitrogen would balance the charge on Arg 386 through the 
3-OH of the coenzyme. The removal of a proton would then 
raise the dissociation constant of the high pH form to 0.21M 
CI". However; a dissociation constant of 10 mM was 
estimated from broadening of the NMR resonance for the 
enzyme labeled with a trifluoromethyl containing group on 
cysteine 390 at pH 8.2 (Critz and Martinez-Carrion, 1977). 
A 10 mM dissociation constant for chloride was also 
estimated spectrophotometrically by Chen (1981) from 
competition with ervthro-3-hydroxyaspartate. Dicarboxylates 
such as 2-oxoglutarate bind to the PLP form of aspartate 
aminotransferase causing a bathochromic shift in the 430 nm 
band and an increase in the pK of the enzyme to about 8.7 
(Jenkins, 1980; Fonda and Johnson, 1970; Jenkins and Fonda, 
1985). 
6-FPLP (Fig 1) is an analog of PLP which was 
synthesized by Chang and Graves (1982). PLP forms mostly a 
dipolar ionic ring in neutral solution (Harris et al., 
1976). The non-dipolar ionic ring form of 6-FPLP is favored 
in neutral aqueous solution. The shift of the 6 proton 
could be used to monitor the state of protonation of the 
ring nitrogen and phenolic hydroxyl (Korytnyk and Ahrens, 
15 
1970) but the NMR resonance can't be resolved in an enzyme. 
The chemical shift of the NMR signal of 6-FPLP also 
monitors the protonation state of the ring nitrogen and 
phenolic hydroxyl (Chang, 1984; Scott et al., 1985). The 
NMR signal of the phosphorylase-bound coenzyme indicates 
that as in the native enzyme the non-dipolar ring is 
stabilized. Glycogen phosphorylase retained 28% of the 
native activity when the apo-enzyme was reconstituted with 
this analog (Chang and Graves, 1985). 
AAT has been studied using various kinds of NMR 
spectroscopy. Martinez-Carrion (1975) concluded that the 
phosphate group of the coenzyme is bound as the di-anion 
from the chemical shift of the NMR signal. The pK of 
the 5'-phosphate has been determined by ^^P NMR and is the 
same as the spectrophotometrically determined pK of the 
internal imine group. This pK rises with the monovalent 
anion concentration as does the spectrophotometric pK 
(Schnackerz, 1984) thus, it appears that the nucleus 
senses this pK. However, dicarboxylate inhibitors lower the 
3ip pK while raising the spectrophotometric pK. The 
position of the ®^P NMR resonance indicates the monoanion is 
favored at low pH and the dianion at high pH but the 
difference (0,5 ppm) is 2.6 ppm less than expected from 
model studies (Schnackerz et al., 1979). Other possible 
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explainations for this shift (Arnone et al., 1985) include 
either distortion of the O-P-0 bond angles (Mattingly et 
al., 1982) or a tautomerism which places a proton on the 
phosphorous for a fraction of the time (12%). Pfister et 
al. (1978) found that peptide proton exchange varied upon 
the addition of substrates. Morino et al. (1984) was able 
to locate the 4' proton and titrate histidine groups in the 
proton NMR of this enzyme. Critz and Martinez-Carrion 
(1977) found linewidth and chemical shift variations of 
trifluoromethyl-modified Cys 390 when substrates and 
chloride ion were added. Succinate, 2-oxoglutarate, and CI" 
induced narrowing of the resonance. L-glutamate, 
2-methylaspartate, and erythro-3-hvdroxyaspartate did not 
change the linewidth. Boettcher and Martinez-Carrion (1975) 
monitored the ^^C NMR spectrum of ^^C=N which had reacted 
with Cys 390. Addition of substrates and substrate analogs 
and pH changes revealed no changes in the ^®C resonance. 
Pyridoxal 5'-sulfate is geometrically similar to 
pyridoxal 5'-phosphate. The major structural difference is 
localized in the sulfur oxygen bond lengths which are 
expected to be 0.06 A' (4%) shorter than the corresponding 
phosphorus-oxygen bond lengths. Sulfur-oxygen bond angles 
are nearly identical to those of the phosphorus-oxygen bonds 
in PLP. Electronic perturbations include one fewer 
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ionizable proton on the esterified sulfate group and 
increased electron withdrawal from the pyridinium ring to 
the sulfate group. 
Substitution of pyridoxal 5'-sulfate for PLP in enzymes 
has been investigated. Matsuda and Makino (1951) found that 
pyridoxal 5'-sulfate is inactive as a coenzyme for glutamate 
decarboxylase isolated from mouse brain. Competition with 
pyridoxal 5'-phosphate for the coenzyme binding site of the 
apo-enzyme was demonstrated. Likos (1977) confirmed this 
observation with glutamate apo-decarboxylase isolated from 
Escherichia coli. using circular dichroism to demonstrate 
binding. Apo-glycogen phosphorylase binds pyridoxal 
5'-sulfate. The aggregation state of the enzyme is 
unchanged from that with PLP but the complex is inactive 
(Shaltiel et al., 1959). Pyridoxal 5'-sulfate doesn't 
appear to bind to apo L-aspartate beta decarboxylase since 
it doesn't induce association to a higher molecular weight 
particle (Tate and Meister, 1959). Pyridoxal 5'-sulfate 
binds to D-serine apo-dehydratase almost as well as does 
pyridoxal 5'-phosphate but the complex is inactive. Apo-
tryptophanase regains 10% and arginine apo-decarboxylase 25% 
of the activity of the PLP reconstituted enzyme with the 
weakly bound pyridoxal 5'-sulfate (Groman et al., 1972). 
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The molecular interactions responsible for the altered 
enzymatic activity of enzymes reconstituted with pyridoxal 
5'-sulfate have not been rigorously determined. Groman et 
al. (1972) concluded that the doubly ionizable 5'-phosphate 
group of pyridoxal 5'-phosphate is not a general requirement 
for either combination with the apo-enzyme or for catalytic 
activity of the complex. However, the presence of a dianion 
may be a requirement for activity in AAT (Furbish et al., 
1959; Metzler and Fonda, ,1985). 
The interaction of pyridoxal 5'-sulfate with aspartate 
apo-aminotransferase has been studied. Yang et al. (1974) 
found that pyridoxal 5'-sulfate covalently modifies 
aspartate apo-aminotransferase. The spectral 
characteristics of the modification product could be 
simulated by reacting beta substituted amines with pyridoxal 
5'-sulfate. Inorganic sulfate was released during this 
reaction. Schmidt (1980) isolated a fluorescent chromophore 
which retained the fluorescence and spectral characteristics 
of the modified enzyme. Schmidt et al. (1982) and Scott et 
al. (1982) characterized the fluorescent chromophore as a 
modified pyrrolopyridine attached at its 2 position to the 
epsilon amino group of lysine 258. This dissertation 
includes a description of the non-enzymatic synthesis of 
this chromophore from pyridoxal 5'-sulfate and primary 
amines which was published by Scott et al. (1982). It also 
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includes further characterization of products formed from 
these pyrrolopyridine derivatives. The proposed mechanism 
for pyrrolopyridine formation (Scott et al., 1982) is shown 
in Fig 4. The pyrrolopyridine ring structure was 
synthesized by Armarego et al. (1972) by reduction of 
pyridine-3,4-dicarboxylic acid to the bis(hydroxymethyl) 
compound, conversion to the bis(chloromethyl) derivative, 
condensation with a primary amine, and dehydrogenation. 
This structure has also been synthesized by Ahmed et al. 
(1979) by condensation of 5-bromo-3-picolyl chloride with an 
N-alkylaminoacetonitrile followed by ring closure with 
potassium amide in liquid ammonia. Other synthetic routes 
to the pyrrolopyridine ring structure are reviewed by White 
and Mann (1969). 
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FIGURE 4. Proposed mechanism for the reaction of pyridoxal 
sulfate with primary amines (Scott et al., 1982) 
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MATERIALS AND METHODS 
The 6-FPLP was synthesized by Chang and Graves (1985). 
The 6-FPMP was prepared by dissolving 6-FPLP (0.4 mg) in 1 
ml 30% aqueous ammonium hydroxide. A few grains of sodium 
borohydride on the tip of a spatula were added to this 
solution. The resulting mixture was concentrated by 
lyophilization and was then applied to a Biogel P-2 column 
(1 X 60 cm). The column was washed with 0.01 M formic acid, 
and the fractions absorbing at 290 nm were pooled (Chang and 
Graves, 1985). The 6-FPMP obtained was characterized by UV 
and NMR spectrocopy. (Chang, 1984). Pyridoxal 
5'-sulfate and the 5'-trans-carboxyethenyl analogue of 
pyridoxal phosphate were prepared in this laboratory 
according to published procedures (Yang et al., 1974; Miura 
and Metzler, 1976). Deuterium oxide "100%" was purchased 
from Merck Sharp & Dohme Canada Ltd., Montreal, Canada. All 
other chemicals were obtained from commercial sources and 
were of reagent grade or better. 
The alpha subform of the cytoplasmic isoenzyme of 
aspartate aminotransferase of pig hearts was prepared by the 
method of Jenkins et al. (1959) as modified by Martinez-
Carrion et al. (1967, method A). The apoenzyme was obtained 
by the procedure of Scardi et al. (1963) as modified by 
Furbish et al. (1969). The 6-FPLP-containing enzyme was 
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prepared by adding 1.2-1.5 mole of 6-FPLP per mole of 
apoenzyme active sites to an approximately 0.4mM solution 
(18 mg/ml) of apoenzyme at pH 8.3 in 0.02 M Tris-acetate 
buffer. After 2 h, the enzyme was dialyzed for 12-24 h with 
3 changes of buffer. Dialysis was continued for a similar 
period at pH 5.4 to remove a small amount of non-
specifically bound 6-FPLP which had a narrow NMR 
resonance at either the position expected for the Schiff 
base of 6-FPLP with valine at high pH or the position of 
6-FPLP at low pH. 
UV-visible absorption spectra were recorded in digital 
form on a Gary 219 spectrophotometer interfaced to an Apple 
2E computer or on a Gary 1501 spectrophotometer as described 
previously (Metzler et al., 1973; Harris et al., 1976; 
Metzler et al., 1980). Resolution with lognormal curves was 
accomplished as described by Metzler et al. (1973), Harris 
et al. (1976), and Metzler et al. (1980). Width and 
skewness values for minor bands were fixed at preselected 
values. An attempt was made to find an internally 
consistent set of band parameters that could be related 
directly to those of the 6-H compounds. The method of 
Nagano and Metzler (1967) was used to evaluate pK values, to 
plot spectrophotometric titration curves, and to calculate 
the spectra of the individual ionic forms of the compounds 
studied. 
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Most of the NMR measurements were made on a Bruker 
WM-300 spectrometer at 282.4 MHz. Low field measurements 
were made on a Bruker FX-90 spectrometer at 86.4 MHz. 
Spectra were collected with a 50-90' pulse width (15-30 x 
10'® s) using 8K data points and an acquisition time of 
0.205 s. The relaxation delay was varied from 0.2 to 5.8 s. 
An exponential multiplication of 20 Hz was applied to the 
free induction decay before Fourier transformation. Peak 
shifts are in reference to external 20mM trifluoroacetate, 
pH 6.8 as 0 ppm. This places fluorobenzene at -38.1 ppm. 
The peaks had a Lorentian line shape. For calculation of 
line widths, 20 Hz was subtracted from the measured widths 
at half height. 
The proton NMR spectra of ethylpyrrolopyridine (Fig. 
47) were run on a JEOL FX-9OQ spectrometer at 89.55 MHz by 
using 2 or 5 mm tubes. One of the spectra was measured on 
about 19 X 10"® mol of compound in 0.5 mL of water at pH 1. 
The conditions employed were similar to those used in the 
inversion recovery method: a 180'-tau-90® pulse sequence 
with a 90° flip angle (52 x 10"® s) and tau = 0.68 s. This 
suppreses the H2O resonance which has a long longitudal 
relaxation time (Ti). Data from 100 scans were accumulated 
on an 8K computer memory. Proton decoupled carbon-13 NMR 
spectra were also run on the JEOL spectrometer at 22.5 MHz 
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by using either 2 or 5 mm tubes. The internal standard was 
dioxane, whose chemical shift was assigned as 65.5 ppm. 
Many of the proton NMR spectra were taken on a Bruker 
WM300 spectrometer using 5 mm sample tubes. Chemical shifts 
were recorded in parts per million (ppm) relative to an 
external standard of tetramethylsilane (TMS) in chloroform 
sealed in a capillary. The internal deuterium lock signal 
was provided by 100% deuterium oxide which also reduced the 
area of the HDO peak to acceptable levels. The value of pD 
was estimated by adding 0.41 to the reading on a Radiometer 
model PHM64 pH meter. The pD was adjusted by addition of 
DCl or NaOD. A 30' flip angle (2.1 x 10'® s pulse) and a 
0.1 s delay time were used for most spectra that were 
measured with water saturation. 
Samples of pyrrolopyridines were prepared for NMR 
spectroscopy by concentrating to 0.1 mL under reduced 
pressure, adding either deuterium oxide or 0.005 M DCl to 
bring the volume to 5 ml, and again reducing the volume to 
0.1 mL. This cycle was repeated 4 or 5 times. 
Lyophilization was avoided because it seemed to promote 
decomposition. 
The mass spectra were obtained with Finnegan 4000 and 
Kratos (AEI) MS902 mass spectrometers. 
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Thin layer chromatography (TLC) was carried out on 8 x 
8 cm precoated silica gel plates (E. Merk-Brinkman, silica 
gel 60) by using primarily the system acetic acid-l-butanol-
water (1:4:1 v/v). 
Solutions of pyridoxal 5'-sulfate at 2.6 x 10"* M and 
an amine at 0.1 M were allowed to react at 22"C. The pH was 
adjusted before the solutions were brought to their final 
volumes with either formic acid or sodium hydroxide, 
depending upon whether an amine or an amino acid was used. 
The reactions and subsequent isolation of the modification 
product were performed with the exclusion of as much light 
as possible since the products are photosensitive. The 
product formation was monitored by measuring the absorbance 
at 400 nm. When this reached a maximum, the solution was 
concentrated under reduced pressure to 0.01 the original 
volume. The pH was then lowered to 3 with concentrated HCl. 
Solutions were always kept at low pH to avoid base-catalyzed 
decomposition. 
The concentrated reaction mixture was fractionated on 
SP-Sephadex. The 1.3 x 40 cm column, which contained about 
0.1 g of the ion exchanger per mole of pyridoxal 5'-sulfate 
reacted with a primary amine, was eluted with an 0.0007-0.5 
M gradient of ammonium formate buffer, pH 2.9. The 
fluorescent product was identified by its characteristic 
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absorption spectrum (Fig. 5). For the reaction with 
ethylamine, it was eluted at a volume between 1.4 and 1.6 L. 
The separation was similar to that shown in Fig. 3 of 
Schmidt et al.,(1982) except that a large peak of unreacted 
pyridoxal sulfate emerged very early and another major peak 
with an absorption maximum at about 312 nm emerged just 
ahead of the fluorescent compound. The fractions containing 
the desired product were concentrated to about 20 x 10"® 
mol/ml under reduced pressure by using a 60° water bath to 
heat the sample. The concentrated sample was diluted 50% 
with 0.01 M formic acid to avoid shrinking the Bio-Gel, 
loaded on a Bio-Gel P-2 column, and eluted with 0.01 M 
formic acid. A 2.8 x 90 cm column was used to separate 
50-70 xlO'G mol of the fluorescent product while an 0.8 x 90 
cm column was used to separate 10 xlO'® mol or less. The 
fluorescent product, which was eluted at a volume of between 
500 and 600 mL, was concentrated under reduced pressure. 
The concentration was estimated by using a molar 
absorptivity of 5.3 x lO^M'^cm'^ at 382 nm, pH<5: yield of 
ethyl pyrrolopyridine (Fig. 6), 20%; yield of propyl 
pyrrol©pyridine (Fig. 5), 12%. 
The pyrrolopyridine product formed with aspartate was 
separated on a 23 x 1 cm Bio-Rad AG1-X8 column (100-200 
mesh) by Mark Shahan, undergraduate research assistant. 
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because the aspartate carboxyl groups prevented separation 
on a SP-Sephadex column. The column was eluted with a 0.01 
to 1 M formic acid gradient. Subsequent separation on a 
Bio-Gel P-2 column was accomplished as described above. 
The reaction rate with alanine at pH 9.5 was monitored 
spectrophotometrically at 382 nm. Pyridoxal 5'-sulfate 
(2.44 X 10"4 M) was reacted with various concentrations of 
alanine in one experiment and alanine (0.091 M) was reacted 
with various concentrations of pyridoxal 5'-sulfate in 
another. Twenty x 10'® 1 of concentrated HCl was added to 
two ml of the reaction mixture to stop the reaction. The 
absorbance changes were linear for 2 h in the first case and 
nearly an hour in the second. 
Solutions of the 5'-trans-carboxyethenyl analog at 2.8 
X 10"'M and 0.1 M ethylamine were allowed to react at 22°C, 
pH 9.0. The reaction was monitored spectrophotometrically. 
After 9 h, the reaction mixture was concentrated under 
reduced pressure, the pH lowered to 3 with concentrated HCl, 
and applied to a Bio-Gel P-2 column in a manner similar to 
that used in the reaction with pyridoxal 5'-sulfate. A 0.5% 
yield (Fig. 6) was obtained. 
Preparation of 7-Acetoxy-2-propyl-6-methyl-2H-pyrrolo 
[3,4-c] pyridine(0-Acetyl-propyl pyrrolopyridine (Fig. 6)). 
Acetylation of ethyl pyrrolopyridine (Fig. 6) was 
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accomplished by adding 5 mL of a 1:1 (v/v) mixture of acetic 
anhydride and pyridine to 1.1 x 10*® mol of the lyophylized 
compound. After standing 12 h at room temperature, the 
mixture was dried under a stream of gaseous nitrogen. The 
residue was extracted with chloroform, the dissolved 
material having an absorption maximum at 327 nm. The 
chloroform was evaporated by a stream of nitrogen, and the 
residue was dissolved in 0.01 M formic acid. 
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RESULTS 
6-Fluoropyridoxal Phosphate 
Nonenzymatic experiments 
Electronic and ^'F'NMR spectra were measured on free 
6-FPMP and on 6-FPLP and its Schiff base with valine. The 
spectra of some individual ionic forms are shown in Fig. 9 
and Fig. 21. The spectra have been analyzed by fitting with 
lognormal distribution curves. Although some of the bands 
are as much as 20% wider than for corresponding 6-H 
compounds, the procedure permits a quantitative accounting 
of the area in complex spectra with overlapping bands. The 
pK values are given in Table 1 with those of related 
compounds. Hydration ratios were calculated from l*F NMR 
areas and ultraviolet-visible spectra fit with log normal 
curves (Table 2). Schiff base formation constants and 
chemical shifts of NMR resonances are given in Tables 2 and 
4 respectively. 
Valine (dipolar ion) reacts with anionic 6-FPLP to form 
the monoanionic Schiff base. The log of the formation 
constant is 3.44, identical to that of PLP itself (Metzler 
et al., 1980). The structures of the two Schiff bases are 
also similar. The two major light absorption bands at 345 
nm and 426 nm can be assigned to the enolimine and 
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FIGURE 7. Enolimine and ketoenamine tautomers 
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TABLE 1. Table of pK values 
Compound Method^ NH+ (ring) -OH 4=NH+ or -NH3+ 
4-F-pheno1 
6-F-pyridoxine^ 
NMR 
S 
NMR 
6-CL-pyridoxine^ S 
6-Br-pyridoxine^ S 
Pyridoxine (microscopic constants)*^ 
cation 
neutral, non-dipolar ionic 
6-FPMP S 
NMR 
PMPc 
cation 
neutral, non-dipolar ionic 
form 
6-FPLP 
PLPC 
cation 
neutral, non-dipolar ionic 
form 
Schiff base of 6-FPLP 
+ DL-valine 
cation 
neutral form 
6-FPLP-containing 
cytosolic AspAT 
Native AspAT® 
6-FPMP-containing AspAT 
S 
S 
S 
S 
S 
NMR 
-0 .2  
0.05 
1 . 1  
1 . 0  
5.63 
4.4 
<0 
3.6 
6.4 
8.24 
8.3 
9.7 
8.2 
8.3 
7.9 
7.7 
8 . 2 0  
7.7 
7.45 
7.6 
7.8 
7.8 
10.94 
8.4 
7.1 
6.4 
%, spectrophotometric; NMR, ^'f nuclear magnetic resonance. 
^Courtesy of C.M. Metzler and W. Korytnyk. 
^Microscopic dissocatinn constants, calculated from data of 
Metzler et al., 1973 and Harris et al., 1976; see also Kallen et 
al., 1985. 
(^Metzler et al., 1980. 
^Varies from 5.4 at low anion concentration to 6.8 in high 
chloride or acetate. 
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TABLE 2. Hydration ratios and formation costants for 6-FPLP 
and 6-FPMP 
From NMR spectra From 
(in D2O) UV-spectra 
6-FPLP 
Hydration ratios [hydrate]/[aldehyde]® 
neutral ring 0.20 0.23 
anion 0.52 0.44 
Formation constant of Schiff base with valine^ Log Kf'=3.44 
Hydration ratio [carbinolamine]/[Schiff base] 
for anion 0.8 
PLP 
Hydration ratios^,*^ 
cation 3.0 4.1 3.2 
dipolar ionic ring 0.20 0.23 0.3 
neutral ring 0.3 
anion 0.03 0.09 
Formation constant of Schiff base Log Kf'=3.44 
with valine^ 
®From ^^F NMR spectra. 
''Kf' = [Monoprotonated Schiff base]/([valine *] [unprotonated 
6-FPLP or PLP]). 
^From proton NMR spectra, Ahrens et al., (1970; first column); 
Kallen et al. (1985; second column); In D2O. 
•^From electronic absorption spectra, Harris et al., (1976). 
®From Metzler et al., (1980). 
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ketoenamine tautomer respectively (Fig. 7). The ratio of 
these (Rsb = [enolimine]/[ketoenamine]) was varied by 
changing the solvent from water up to 95% methanol, in which 
the ketoenamine tautomer (Fig. 7) is strongly favored as is 
indicated by an increase in the 345 nm absorption band and a 
drop in the 425 nm band (Table 7, Fig. 8). Rsb was 
estimated using areas obtained by fitting the absorption 
spectra with lognormal curves, assuming that the two 
tautomers are the only species present, and that molar area 
doesn't vary with solvent (Metzler et al., 1973). The 
unprotonated form of the Schiff base has an unusually broad 
absorption band (Fig. 9) which is consistent with the 
presence of both carbinolamine and Schiff base in nearly 
equal amounts as is indicated by the ^®F NMR spectrum (Fig. 
10) (Table 4). 
A preliminary test of the non-enzymatic reactivity of 
6-FPLP with an amino acid was made by incubating a solution 
containing ImM 6-FPLP, lllmM L-glutamate and 1 mM KA1(S04)2, 
pH 5.0 (Metzler and Snell, 1952) at 42'C for llh and 
subsequently at room temperature for 21 days. The UV-
visible absorption spectrum was monitored in a closed fused 
silica cuvette containing a 9.5mm silica spacer (to give a 
path length of 0.50 mm). A control was run with PLP instead 
of 6-FPLP. The UV-visible absorption spectrum was recorded 
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SCHIFF BASE 
FREE 6-FPLP 
CARBINOLAMINE 
FIGURE 10. Amount of Schiff base, carbinolamine, and free 
6-FPLP in a solution 0.3mM in 6-FPLP and O.IM in 
valine versus pH as determined by ^'F NMR 
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at various times. Over a period of 3 h the spectrum of the 
PLP-containing control solution changed rapidly to give a 
strong PMP band at 333 nm. However, the 6-FPLP-containing 
solution underwent an insignificant amount of spectral 
change even after 8 d (Fig. 11). The reactivity of 6-FPLP 
in non-enzymatic reactions is very much less than that of 
the natural coenzyme. As with the Schiff bases of PLP 
itself, (Metzlet et al., 1980; Kallen et al., 1985) the pK 
of the chelated proton in the mixture of enolimine and 
ketoenamine (Fig. 7) is 12.33 for the Schiff base with 
valine. 
Interaction of coenzyme analogues with aspartate 
aminotransferase 
Binding of 6-FPLP to apo-aspartate aminotransferase 
within the pH range of 6-8.5 is rapid and tight. After 
incubation of 0.1 mM apoenzyme with a 10-20% excess of the 
analogue, the remaining free 6-FPLP can be dialyzed cut. 
Prolonged dialysis (up to 100 h at pH 8.3 and 50 h at pH 
5.4) then causes little or no additional loss of the 
fluorinated coenzyme. However, in the crystalline state at 
pH 5.4 a major fraction of the 6-FPLP was lost from one 
subunit (subunit 1, see Arnone et al., 1982, 1984, 1985; 
Metzler et al., 1982) and a lesser amount from the other (A. 
Arnone, private communication). Thus, the binding is less 
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tight than for PLP itself. The binding of 6-FPLP to 
apoenzyme was done under conditions that provide for over 
95% reactivation of apoenzyme by PLP. Reconstitution of 
0.15 mm apo-enzyme with 6-FPLP was monitored 
spectrophotometrically at 374 nm. The solution was allowed 
to equilibrate for 2 h after each addition of 6-FPLP. A 
nearly linear relationship between the amount of 6-FPLP 
added and absorbance of the enzyme at 375 nm was obtained 
(Fig. 12). 
The absorption spectrum of the 6-FPLP-containing enzyme 
(E-FPLP) is shown in Fig. 13 together with that of the 
native enzyme. At pH 5.4, there are again two absorption 
bands, one at 345 nm and a larger one at 447 nm. We believe 
that as with the free Schiff bases these correspond to the 
enolimine and ketoenamine tautomers (Fig. 7) respectively. 
However, it is not immediately clear whether the ring 
nitrogen is protonated or whether the proton normally on the 
ring has been transferred wholly or in part to the Asp 222 
carboxylate group (Fig. 2). X-ray diffraction studies 
(Arnone, private communication) confirm that Lys 258 
provides the amino group for this Schiff base as in the 
native enzyme and 6-FPLP occupies nearly the same position 
as PLP (Fig. 14). The absorption spectrum of E-FPLP in 20 
mM Tris-acetate buffers changes with a pK of 7.0 at lO'C 
42 
_L JL 
0.1 0.2 0Ô u4 0.5 0.5 0.7 
EQUIVALENTS 6-FPLP ADDED 
0.3 iC 
FIGURE 12. Reconstitution of apo-AAT with 6-FPLP 
8 
7 
6 
5 
4 
3 
2 
1 
0 
8 
7 
6 
5 
4 
3 
2 
1 
43 
"7* 
+Malate 
WAVE NUMBER (cm'b « 10'^  
50 500 450 400 350 
WAVELENGTH (nm) 
320 300 280 
-visible absorption spectra of 5-FPLP in AAT 
mpared with those of native AAT 
44 
(Fig 13), the high pH spectrum having a maximum at 375 nm, 
appropriate for a dipolar ionic Schiff base as in the native 
enzyme (Fig. 2). The low value of the pK is suggestive of a 
dipolar ionic coenzyme ring. 
The pK of the E-FPLP complex is sensitive to the anion 
concentration, rising to 7.7 in the presence of 0.5 M sodium 
acetate at 10"C. With E-FPLP glutarate, succinate, malate 
and meso-tartrate also induce a bathochromic shift of 3-4nm 
(Fig. 13, Table 3). The pK is raised to above 9 in the 
presence of 10 mM 2-oxoglutarate. The tautomeric ratio Rsb 
(=[enolimine]/[ketoenamine]) is decreased in the 
dicarboxylate complexes from about 2.1 in the free enzyme in 
0.04 M acetate buffer, pH 5.4 to about 1.0 in the succinate 
and 0.6 in the L-malate complexes (Table 3, Fig. 15). 
However, little effect is seen with 2-oxoglutarate or 
acetylene dicarboxylate. As with native enzyme, the 
absorption spectrum of E-FPLP is affected only slightly by 
changes in temperature over the range 2'C - 20°C (Fig. 17). 
Enzymatic activity 
The 6-FPLP-containing aspartate aminotransferase has 
42% as much activity as PLP when added back to apoenzymes 
judging by the maximum velocity of the enzyme-catalyzed 
reaction of aspartate with 2-oxoglutarate. This velocity 
together with the four Michaelis constants were measured by 
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FIGURE 14. Difference electron density map of E-FPLP with 
native AAT courtesy A. Arnone. Solid line = 
positive density. Dashed line = negative density 
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15. Dependence of the chemical shift upon the 
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schiff base of F-PLP in water-methanol solvent 
mixtures. B = E-FPLP and a searies of its 
dicarboxylate complexes 
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FIGURE 16. Fluorine-19 NMR spectra of 6-FPLP in AAT shifted 
by dicarboxylate inhibitors 
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FIGURE 17. Variation in UV-visible absorption peak area 
with temperature. Circles, 445 nm peak. 
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TABLE 3. Molar areas and bandshapes of ultra-violet visible 
absorption spectra of E-FPLP and dicarboxylates 
fit with lognormal curves 
Aspartate aminotransferase + 6-fluoro PLP (E-FPLP) 
Position Height Width Skewness Area 
XQ VQ eg W Pa 
(nm) (cm~^xlO~^) (n/mol x 
10^ y 
pH 5.4 (A200.01) 
445.0 22.47 2.29 4.91 1.68 126.3 
Fine structure 20.4 4 .2% 
22.0 1 4.6% 
340.7 29.35 3.68 6.18 1.50 250.0 
Second preparation 
At 2 'C (A200.02) 
446.2 22.41 2.20 4.63 1.64 113.9 
345.1 28.98 3.24 5.37 1.45 190.4 
10" (A200.03) 
447.0 22.37 2.235 4.62 1.65 115.3 
345.1 28.98 3.17 5.49 1.47 190.6 
20* (A200.04) 
447.6 22.34 2.31 4.62 1.65 119.3 
345.1 28.98 3.14 5.57 1.47 191.4 
(A200.06) Reference so lut ion for malate-binding expt 
446.8 22.38 2.32 4.55 1.60 117.6 
343.5 29.11 3.62 5.18 1.31 202.0 
(A200.07) Reference solut ion for 2-oxoglutarate and oxaloacecac p—h i nd1 
experiments 
447.6 22.34 2.37 4.48 1.60 117.8 
340.0 29.40 4.00 5.81 1.29 250.6 
(A200.08) Reference solution for meso-tartrate and acetylene 
decarboxylate binding 
22.36 2.31 4.58 1.64 118.2 
29.11 3.57 5.19 1.31 200.3 
pH 8.3 small 27.47 .343 4.70 1.59 17.9 
amount of 
low pH form 
375.2 26.65 6,55 4.50 1.505 323.9 
316.7 31.58 1.17 4.50 1.47 57.7 
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TABLE 3 (Continued) 
6-FPMP + apo AspAT 
Position Height Width Skewness Area 
Xq VQ EQ W p a 
(nto) (cm~^xlO~^) (M~^cin~M (cm~^xlO~^) (n/mol x 
1 2 . 1  
HP form 24.7 
341.2 29.25 6.56 3.73 1.60 271.7 
308.5 
P form 
233.1 
324.8 30.79 6.40 3.36 1.355 +64.6 
297.7 
E-FPLP + Dicarboxylates 
50 mM Malate (A211.01) Reference solution A200.06 
448.0 22.32 5.10 4.02 1.52 225.5 
337.3 29.65 2.19 5.23 1.30 123.5 
50 mM meso-tartrate (A217.01) Reference solution A200.08 
443.7 22.54 4.525 4.29 1.49 213.1 
338.9 29.51 2.04 5.09 1.30 111.8 
Acetylene dicarboxylate. Reference solution A200.08 
50 mM (A213.01) 
444.8 22.48 2.56 4.55 1.56 129.0 
342.7 29.18 3.41 5.17 1.35 190.95 
100 mM (A213.02) 
444.8 22.48 2.59 4.56 1.57 130.8 
342.3 29.21 3.44 5.29 1.38 197.6 
E-FPLP + 2-oxoelutarate, pH 5.4 50 mM (A214.01) 
22.14 2.505 4.55 1.58 126.6 
29.60 4.08 5.94 1.385 263.35 
100 mM {A214.02) 
2.23 2.87 4.73 1.54 149.7 
29.71 4.76 5.78 1.19 295.0 
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TABLE 3 (Continued) 
E-FPLP + 50 mM Succinate 
Position 
^0 yo 
(nm) (cm~^xlO~^) 
Height Width 
EQ W 
(M-lcm-1) (cm-^xlO-3) 
Skewness Area 
' a 
(n/mol X 
— 
2'C (A212.01) 
453.3 22.06 
342.1 29.32 
lO'C (A212.02) 
453.7 22.04 
341.8 29.26 
20*C (A212.03) 
454.3 22.01 
Fine structure 
341.6 29.27 
20.4 
3.64 
2.32 
3.77 
2.23 
3.95 
10.0% 
2.15 
4.18 
5.69 
4.19 
5.79 
4.16 
5.89 
1.50 
1.47 
1.51 
1.49 
1.50 
1.49 
167.1 
144.6 
173.5 
141.5 
180.7 
138,9 
Very much enhanced vibrational structure 
E-FPLP + 50 mM Glutarate 
2'C (A21S,01) 
453.1 22.07 
341.3 29.30 
lO'C (A215.02) 
453.5 22.05 
341.3 29.30 
20*0 (A215.03) 
453.7 22.04 
Fine structure 
341.2 29.31 
2.90 
2 .68  
2.97 
2 . 6 2  
3.06 
20.3 
22.0  
4.20 
5.45 
4.19 
5.46 
4.18 
7.0% 
2.54 5.51 
1.51 
1.42 
1.51 
1.42 
1.50 
1.42 
134.3 
159.4 
136.8 
155.8 
140.6 
152.7 
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TABLE 3 (Continued) 
E-FPLP + Z-Methylaspartate 
Position Height Width Skewness Area 
Xn 
nm) 
Vo , 
(cm-lxlO-3) m 
o
 W p 
(cm"^xl0~^) 
a 
(n/mol X 
450.4 22.20 4.96 4.24 1.45 
lo"^) 
230.2 
375.9 26.60 0.338 4.27 1.50 15.9 
341.9 29.25 1.48 5.50 1.47 89.4 
317.6 31.69 1.38 4.50 1.47 68.1 
a" fraction % 
450.4 346 .665 54 Aldimine, ketoenamii 
375.9 342 .046 3.7 Michaelis complex 
341.9 294 .304 24 Aldimine, enolimine 
317.6 300 .227 18 Carbinolamine 
1.24 100 
If we assume that the 317.6 nm band can be ignored because 
it represents a second band for the aldimine then: 
450.4 
375.9 
341.9 
fraction 
.665 
.046 
.304 
Z 
6? 
4.5 
30 
Of aldimine 68.6% is ketoenamine 
31.4% is enolimine 
Chemical shift for NMR signal = -30.1 ppm. 
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TABLE 3 (Continued) 
E-FPLP + erythro-3-hydroxyaspartate 
Position 
^0 Vo , 
(nm) (cm~^xlO~') 
Height 
GO , 
(M-lcm-1) 
Width Skewness 
W p 
(cm-lxlO-3) 
Area 
a 
(n/mol X 
10"^) 
+2'C (A242. 01) 
491.4 20.35 21.58 2.13 1.68 515.6 
389.9 25.65 2.76 3.94 1.92 125.7 
329.9 30.31 3.34 6.28 2.12 250.0 
tlO'C (A242.02) 
491.4 20.35 21,84 2.14 1.66 523.7 
389.7 25.66 2.80 3.89 1.86 125.1 
329.9 30.31 3.23 6.05 2.01 229.0 
+20-C (A242.03) 
491.2 20.36 22.55 2.17 1.65 546.6 
389.6 25.67 2.91 3.84 1.83 127.7 
329.9 30.31 3.07 5.60 1.82 196.4 
Second sample 
489.2 20.44 20.02 2.19 1.66 490.1 
388.0 25.77 2.595 3.41 1.52 97.4 
333.6 29.98 2.35 4.11 1.38 104.9 
For A240.01 (2°C) Fractions present 
a* a/ a* l^F-NMR ISp Chemical Shift 
Quinonoid 491.4 816 .632 (by difference) .629 -36 .6 
Michaelis 
Gcmp lex (?) 389.9 3'! 2* .368 .371 -34, »4 
1.00 1.00 
For A242.03 (20'C) 
491.2 816 
389.6 342 
329.9 396 (Assumed to be second band of quinonoid form) 
64.4% .667 .670 
.373 
1.043 
The fact that the -36.6 ppm band and the 491 nm band increase with 
temperature suggests that they both represent quinonoid form. 
^Estimated for dipolar ionic species in native enzyme. 
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the methods of Kiick and Cook (1983) (Fig. 18) and are given 
in Table 5 where they are compared with the same parameters 
for native enzyme. The Km values are lower than those 
obtained by Kiick and Cook (1983) but comparable to values 
obtained by Velick and Vavra (1962). E-FPLP binds 
2-oxoglutarate 14 times more tightly then native AAT. 
Electronic spectra of substrate complexes 
Native aspartate aminotransferase is converted by the 
inhibitory quasi-substrate 2-methylaspartate to a complex 
with absorption bands at 430 and 369 nm of approximately 
equal intensity (Fasella et al., 1966; Kallen et al., 1985). 
The 430 nm band has greatly diminished circular dichroism 
and is thought to represent the Schiff base of the inhibitor 
with the coenzyme. The 360 nm band may represent the first 
complex (the "Michaelis complex") with the inhibitor. With 
E-FPLP a similar complex is formed with 2-methylaspartate, 
the dissociation constant being less than 1 mM at pH 8.3. 
However, with the fluorinated coenzyme the 451 nm 
ketoenamine band of the external Schiff base is the major 
band. The smaller band at 340 nm (Fig. 19) probably 
represents, in part, the corresponding enolimine. It is 
evident from attempts to resolve the spectrum with lognormal 
curves that additional absorption bands are also present. 
The smaller of these probably matches the high pH dipolar 
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TABLE 4. Fluorine-19 NMR data 
Fluoride ion, F" 
Fluorobenzene 
2-Fluoropyridine 
neutral 
cation (12 M HCl) 
4-Fluorophenol 
neutral 
anion 
3-Fluorobenzylamine 
cation 
neutral 
6-Fluoropyridoxine 
cation 
neutral 
anion 
6-FPMP 
monocation (neutral ring) 
dipolar ion (ring 
unprotonated) 
Chemical shift width 
ppm relative to TFA® (Hz) 
In H?0 Other Solvent 
Tl 
(s) 
-44.1 
-38.2 
4.75 
-5.4 
-49.5 
56.6 
-37.2 
•38.5 
-24 
-10 
-19.6 
-8 .2  
-18.9 
-34.5 (CHCl3)b 
10.8 (Dimethyl-
formamide)^ 
-49.0 (CCl4)< 
2 
2 
18 
18 
2 
2 
2 
2 
4.6 
1.3 
^External standard: trifluoroacetic acid, 2 mM, pH 6.8. Positions 
given for benzene derivatives are the centers of multiplets arising 
from coupling of F to H atoms attached to ring. For pyridine, a 
broad singlet was observed in each case. 
^From Dewar and Kelemer (1968). 
^From Ems ley and Phillips (1971, p. 345). 
^From Chang (1984). 
TABLE 4 (Continued) 
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Chemical shift width Ti(s) 
ppm relative to TFA® (Hz) 
In HgO Other Solvent 
6-FPLP 
neutral, aldehyde -12.1 8 1 c 
hydrate -10.4 8 1.3 ° 
anion, aldehyde -22.4 8 
hydrate -18.3 8 
Schiff base of 6-FPLP 
with valine 
neutral, enolimine + -19.8 8 0.95 
ketoenamine 
anion ring -16.8 
anionic carbinolamine -18.4 
E-FPLP 
low pH -20.7 200 0.55 
high pH -36.2 200 0.77 
Complexes of E-FPLP 
+ 2-Oxoglutarate, pH 5,4 
or 8.3 -20.7 120 
+ 2-Methylaspartate, 
pH 5.4 -30.1 80 0.6 
minor band -20.3 
+ L-glutamate, pH 5.4 
or 8.3 -32.0 600 0.9 
minor band -20.5 280 0.9 
+L-A3partate -30.6 260 
+ DL-erythro-3-hydroxy-
aspartate 
major band -36.6 100 0.7 
minor band -34.4 100 1.3 
+ Succinate -23.68 0.45 
+ Glutarate -21.38 0.45 
6-FPMP + Apo AspAT 
pH 8 -35.3 9nn 
Generated in situ with -22.3 
cysteine suTFinate 
pH 5 -35.3 
200 
pH 9 -22.1 0.9 
+ Erythro-3-hydroxya8partate 
+ 50 raM glutarate, pH 8.3 -35.23 170 
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FIGURE 18. Double reciprocal plots for the rate of reaction 
of E-FPLP. Courtesy Y.-C. Chang 
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TABLE S. Kinetic Parameters of Apo-AAT Reconstituted with 
either 6-FPLP or PLP at pH 8.3, 25"C 
+ 6-FPLP + PLP Native holoenzyme 
Vmax (8-1) 73 193 160b 300= 
K^, 2-oxoglutarate (mM) 0.003 0.043 0.82 0.1 
K^, Aspartate (mM) 0.3 1.65 6.6 0.9 
^Buffer: 
^Kiick and Cook (1983), 
(^Velick and Vavra (1962). 
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ion at 375 nm and corresponds to the much stronger 360 nm 
band seen in the 2-methylaspartate complex of native enzyme 
and attributed to the Michaelis complex. Another, at 320 
nm, may be a carbinolamine or a geminal diamine. From the 
areas of the four bands we estimate the following 
percentages: ketoenamine, (Fig. 7), 56%, 375 nm band, 
(Michaelis complex), 5%, enolimine, (Fig. 7), 19% and 320 nm 
band, 20%. The tautomeric ratio R drops from 2.0 in the 
free enzyme to 0.46 in the complex. 
The substrates L-glutamate and L-asparate form 
complexes with E-FPLP having a more or less normal 
distribution of components including a 458 nm band and a 
small guinonoid band at 490 nm (Fig. 19). With the very 
slow substrate erythro-3-hydroxyasparate, a strong guinonoid 
band appears at 491 nm as well as bands at 390 and 330 nm. 
The area of the 491 nm band increases by 10% when the 
temperature is raised from 2'C to 20''C. All of the spectra 
have been analyzed by fitting with lognormal curves; 
approximate molar areas and fractions estimated for 
different components are given in Table 6. 
Electronic spectrum of enzyme-bound 6-fluoropyridoxal 
phosphate 
As with native enzyme, the E-FPLP can be converted 
quantitatively to the E-FPMP form by treatment with L-
60 
+ 2-Methylaspartate 
* erythro-3-Hydroxyatpartate 
X 
i 
S s 
i 
WAVE NUMBER (cm ') "10" 
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FIGURE 19. Spectrum of 6-FPLP-containing AAT after reaction 
with 50mM 2-methylaspartate, 5mM L-
erythro-3-hydroxyaspartate, and 50mM L-glutamate 
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TABLE 6. Molar areas of F-PLP, F-PMP, and F-PN from UV-
visible spectra 
Pos ition 
^0 VO 
(nm) (cm""^xlO" 
Height 
_ fO , 
Width 
W 
(cm""^xlO" 
Skewness 
•3, ' 
Area 
a 
(n/mol X 
HP form 355.6 
291.0 
243.8 
28.12 
34.36 
41.02 
3.53 
0.99 
3.59 
4.89 
3.95 
4.48 
1.31 
1.67 
1.12 
10^6) 
186.5 
43.7 
171.6 
P form 400.2 
316.7 
279.6 
254.3 
24.99 
31.58 
35.77 
39.32 
4.14 
2.03 
0.185 
2.07 
4.66 
3.59 
3.50 
4.25 
1.36 
1.44 
1.40 
1.30 
209.2 
79.5 
7.1 
94.9 
6-Fluoropyridoxamine 5-'phosphate 
H2P form 290.3 
Fine structure 
34.45 
33.2 
6.77 
0 
3.63 
.8%. 
1 .44 268.2 
280.7 
(corrected) 
HP form 321.2 31.13 6.79 3.65 1 .44 270.6 
P form 317.4 31.51 7.88 3.34 1 .38 285.8 
6-Fluoropyridoxine 
H2P form 302.4 
Fine structure 
33.07 
32.44 
10.50 
3. 
2.97 
0% 
1.35 338.0 
HP form 288.4 
Fine structure 33 
34.67 
.4 1.2% 
5.85 3.53 1.39 224.5 
P form 319.4 31.31 6.32 3.64 1.36 249.5 
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cysteine sulfinate. However, the transformation is not 
instantaneous, a strong quinonoid band appearing at 491 nm 
and decaying over a period of about 10 seconds (Fig. 20). 
The spectrum of the enzyme resulting from addition of 1.2 
equivalents of cysteine sulfinate and passage through a gel 
filtration column is shown in Fig. 21. Unlike that of 
native enzyme, this spectrum is pH dependent, the absorption 
maximum shifting from 341 nm at low pH to 325 nm at high pH 
around a pK value of 8.24. When chemically synthesized 
6-FPMP was recombined with apo-aspartate aminotransferase 
identically the same absorption spectra were generated. 
Addition of glutarate at pH 8.5 shifted the peak to 341 nm 
(Fig. 22) as does increased temperature (Fig. 23). 
Fluorine NMR spectra 
The positions of the ^'F resonances as well as the band 
widths are given in Table 4 for 6-fluoropyridoxine, 6-FPMP, 
6-FPLP and its Schiff base with valine, for fluoride and 
other reference compounds. For the benzenoid reference 
compounds multiplets of narrow (2 Hz in water, 1 Hz in 
methanol) bands were observed in all cases. These showed 
the expected couplings to the hydrogen atoms present on the 
ring. For the pyridine derivatives, no coupling was seen 
but only a broader singlet. The titration curves for 
4-fluorophenol and 2-fluoropyridine are shown in Fig. 24 and 
the titration curve for 3-fluorobenzylamine in Fig. 25. 
FIGURE 20. Absorption spectra of E-FPLP + cysteine sulfinic 
acid with time 
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FIGURE 21. Absorption spectra of individual ionic forms of 
6-FPMP. Top panel. Free compound. Lower 
panel. Bound to apo-aspartate aminotransferase 
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FIGURE 22. Change in the uv-visible absorption spectrum 
upon addition of glutarate to 6-FPMP in AAT at 
pH 8.3 
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FIGURE 23. Change in the uv-visible absorption spectrim 
upon increasing the temperature of 6-FPMP in AAT 
at pH 8.3 
57 
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FIGURE 24. Fluorine-19 NMR titration curve of 
4-fluorophenol and 2-fluoropyridine 
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3-FLUORQBENZYLAMINE 
FIGURE 25. Fluorine-19 NMR titration curve for 
3-fluorobenzylamine 
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For the vitamin B6 derivatives, band widths were about 8 Hz 
in all cases. The widths of the broader bands of the 
enzyme-bound coenzyme analogs are strongly dependent upon 
the anion concentration. The 340 Hz width of the band in 10 
mM cacodylate of 0.6 mm E-FPLP is lowered to 180 Hz upon 
addition of sodium chloride, the half saturating CI" 
concentration being 10 mM at both pH 5.4 and 9.1 (Fig. 26). 
Peak width also changes with temperature (Fig. 27), field 
strength (Fig. 29), and concentration (Fig. 28). 
Dissociation of the phenolic hydroxyl of the 
fluorinated coenzymes produced the expected upfield 
(downfrequency) shift. This amounted to -9.6, -10.7, -10.3 
and -7.9 ppm for 6-fluoropyridoxine, 6-FPMP, 6-FPLP 
(aldehyde) and 6-FPLP (covalent hydrate), respectively. 
However, for the Schiff base with valine a downfield 
(upfrequency) shift of 3.2 ppm accompanies this dissociation 
(Fig. 30). 
Ortho-fluoropyridines are so weakly basic that it is 
difficult to completely protonate the ring nitrogen. 
However, for 6-fluoropyridoxine, whose pK is about 0, it is 
clear that N-protonation gives a 14 ppm upfield shift (Fig. 
31, and Table 4). An upfield shift of 10.2 ppm is seen with 
2-fluoropyridine in concentrated HCl (Table 4, Fig. 24), 
because the nitrogen is not completely protonated. 
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FIGURE 26. Variation of fluorine 19 NMR linewidths of 
6-FPLP in AAT with NaCl concentration. Squares 
= pH 5.4, -20.7 ppra peak. Triangles = pH 8.5, 
-36.2 ppra peak 
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FIGURE 27. Variation of ^'F linewidth with temperature. 
Circles, -36.4 ppm peak. Triangles, -21.7 ppm 
peak 
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FIGURE 28. Variation of ^^F linewidth with concentration. 
Circles = in 10 mM cacodylate, pH 5.4. Squares 
= in 20 mM Tris-acetate, pH 5.4 
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FIGURE 29. Variation of ^'F NMR linewidth with field 
strength. Circles, pH 5.4. Squares, pH 8.3. 
Triangles, pH 8.3 + 50mm L-glutamate. Diamonds, 
PMP form pH 8.3. Pentagons, 2=methylaspartate 
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FIGURE 30. Fluorine-19 NMR shifts of 6-FPLP + valine versus 
pH. Approximate amounts are derived from ^'F 
NMR peak areas 
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FIGURE 31. Fluorine-19 NMR titration of 6-fluoropyridoxine 
76 
When the solvent for the Schiff base of 6-FPLP + valine 
is changed from water to water-methanol mixtures of 
increasing methanol content, the resonance moves from 
-19.8 downfield (upfrequency) to -16.9 ppm in 95% methanol. 
When the ratio of enolimine to ketoenamine (calculated from 
the data of Table 7) is plotted against the chemical 
shift a nearly linear relationship is observed (Fig. 15, top 
panel). 
When bound to apo-aspartate aminotransferase 6-FPLP has 
a single NMR resonance at -20.7 ppm (Table 4) despite the 
fact that there are two absorption bands representing 
distinctly different tautomers. This proposed tautomerism 
must involve rapid proton movement between enolimine and 
ketoenamine (Fig. 7) in the model Schiff base and between 
corresponding forms in the enzyme. On the other hand, when 
the pH of E-FPLP is raised from 5.4 to 8 the -20.7 ppm band 
drops in intensity and broadens somewhat while a new 
resonance, representing the dipolar ion arises at -36.2 ppm 
(Scott et al., 1983; Fig. 32). These results show that, 
despite the rapidity of its movement between the 3'-0 and 
imine N, the chelated proton in the internal Schiff base 
exchanges out slowly compared with the NMR time constant of 
3 ns. The width of the -35.2 ppm peak for a solution of E-
FPLP at pH 5.7 was 850 hz. An exchange rate of 0.0012 s was 
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TABLE 7. Molar 
water-
areas of 5-FPLP + valine 
methanol mixtures 
Schiff bases in 
, ^9 (nm) 
Position 
VQ 
(cm~^10~^) 
Height 
GQ 
(M-lcm-1) 
Width 
W 
(cm-lxlO-3] 
Skewness Area 
P a 
1 (n/mol X 
Series 1 
10"°) 
0 428. 6 23. 33 4. 67 4. 26 1. 44 217, .4 
(S30.02) 243. ,8 41. 02 3. 59 4. 48 1. 12 171, 6 
278, .1 
40 431. 2 23. 19 4. 75 4. ,23 1, 46 220 .0 
(S30.03) 341. ,8 29. ,26 1. 60 4. 62 1. ,33 79 .8 
295 .3 
60 432. ,3 23. 13 4. 47 4. 26 1, .48 208 .9 
(S30.04) 343, ,2 29. 14 2. 15 4. 64 1, 44 108 .8 
299 .8 
76 433, ,3 23. 08 3, .32 4, 32 1 .50 157 .8 
(S30.05) 343, .4 29, 12 2. ,56 4, 78 1 .46 134 .1 
291 .9 
88.8 433, .7 23, .06 2. ,54 4, .34 1 .51 121 .5 
(S30.06) 344 .7 29 .01 2, .78 4 ,70 1 .52 144 .1 
265 .6 
95 434 .0 23 .04 1 .98 4 .81 1 .72 107 .5 
(S30.07) 344 .5 29 .03 3 .17 4 .63 1 .55 162 .2 
269.7 
Series 2 
(S30.08) 
60 
(S30.09) 
78.5 
(S30.10) 
88 
(S30.ll) 
428.6 
341.4 
432.3 
343.2 
433.3 
343.3 
435.3 
343.6 
23.33 
29.29 
23.13 
29.14 
23.08 
29.13 
22.97 
29.10 
4.97 
1 . 2 1  
4.42 
2.17 
3.66 
2.71 
2.81  
3.27 
4.25 
4.895 
4.26 
4.65 
4.39 
4.76 
4.45 
4.63 
1.44 
1.42 
1.49 
1.44 
1.55 
1.50 
1.57 
1.40 
231.0 
64.35 
295 .3 
206 .9 
110 .3 
317 .2 
177 .8 
141 .9 
il9 .7 
138 .6 
164 .6 
302.2 
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TABLE 7 (Continued) 
Area of band 1 NMR 
Area of Area of band Fraction^ Corrected Chemical 
% Methanol Band 2 2 .78 a'(l) /a*(2) R Fractions Shift 
Series 1 
0 217.4 .713 .737 
60.7 .78 = 77.8 .255 .358 .263 
295.2 .968 
40 220.0 .721 .683 
79.8 102.3 .335 .465 .317 
322.3 1.056 
60 208.9 .685 .600 
108.8 139.5 .457 .667 .400 
348.4 1.142 
76 157.8 .517 .479 
134.1 71.9 .563 1.089 .521 
329.7 1.080 
88.8 121.5 .398 .397 
144.1 184.7 .605 1.52 .603 
306.2 1.003 
107.5 .352 .340 
162.2 207.9 .682 1.937 .660 
Series 2 
n 
315.4 1.034 
64.35 82.5 .270 .357 .263 
313.5 1.027 
60 206.9 .678 .594 
110.3 141.4 .464 .675 .406 
348.3 1.142 
78.5 177.8 .583 .494 
141.9 181.9 .596 1.022 .506 
359.7 1.179 
88 138.6 .454 .396 
164.6 211.0 .692 1.524 .604 
349.6 1.146 
-19.76 
-19.67 
-19.03 
-18.22 
-17.57 
-16.92 
-19.81 
-19.07 
-18.31 
-17.52 
^ a"(1) = 305 for H2O; higher in methanol, 
a'(2) = 238. 
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calculated for this solution using Nicolet Magnetics 
Corporation program XCH. 
The -20.7 ppm resonance is shifted further upfield 
(downfrequency) (Fig. 15 bottom panel and Fig. 15) when 
dicarboxylate inhibitors are added and the tautomeric ratio 
Rsb is increased (Table 3). The effect is greatest for L-
malate and meso-tartrate and is small for the 5-carbon 
glutarate. From Fig. 15, it is apparent that in a plot of 
^'F chemical shift versus tautomeric ratio complex lies 
almost on the same curve as the simpler dicarboxylate 
complexes. NMR spectra of enzyme-inhibitor and enzyme 
substrate complexes are shown in Fig. 33 (Scott et al., 
1984). 
The ^'F NMR spectrum of 6-FPMP bound to the apoenzyme 
is a singlet at -35.3 ppm which decreases and reappears at 
-22.1 ppm as the pH is raised from 5 to 9 (Fig. 34) around 
the spectrophotometrically determined pK of 8.2 (Fig. 21). 
Thus, in this case too, the rate of exchange of the 
dissociable proton is slow on the NMR time scale, A plot of 
the area of the N-deprotonated form versus pH is shown in 
Fig. 35. At pH 8.3, both the -22.1 and -35.3 ppm resonances 
are observed. When 50mm sodium glutarate was added, the 
-22.1 ppm peak almost disappeared and the -35.3 peak 
increased. This indicates that dicarboxylates bind to the 
B-FPLP + APO-AAT 
PH 8,3 
PH 7.4 
PH 7.0 
PH 5.4 
-iS -éo -ës -ëo -ës -40 -45 
PPM 
FIGURE 32. Fluorine-19 NMR spectrum of 6-FPLP in AAT at 
various pH values 
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6-FPLP + APO-AAT 
+ L-GLUTRMRTE 
+ 2-METHYLASPARTATE 
+ L-ASPARTATE 
+ ERYTHRD-3-HYDROXYASPARTATE 
-iz ^^ ::*r—=^5 ^ =4S-
PPM 
FIGURE 33. Fluorine-19 NMR spectra of inhibitor and 
substrate complexes of 6-FPLP in AAT 
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8.97 
8.38 
8.10 
7.72 
-20"^  2^5" 
CHEMICAL SHIFT (PPM) 
FIGURE 34. Fluorine-19 NMR of 6-FPMP in AAT at various pH 
values 
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J^IOO 
I- 80 
< 60 
40 
20 
FIGURE 35. Area of the ^'F NMR signal arising from the 
deprotonated pyridinium nitrogen of 6-FPMP in 
AAT versus pH. Data fit with a theoretical 
curve 
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low pH form of E-FPMP and raise its pK as with the native 
PLP enzyme. With no observable pK, this effect can not be 
measured for the native PMP enzyme. 
Titration of E-FPLP at pH 5.4 with DL-2-methyl 
aspartate results in a gradual decrease in the -20.7 peak 
and an increase in the -30.1 ppm peak. A Kd of 2.2 mM for 
the L isomer estimated from half saturation was obtained 
(Fig. 36). At 5"C, the saturated enzyme still contained 24% 
of the -20.7 ppm peak. This peak decreased to 10% of the 
total area at 25'C (Fig. 37). The width of the -30.1 ppm 
peak decreased with temperature (Fig. 38). A plot of 
1/linewidth (Hz) versus 1/log temperature ("K) (Arrhenius 
plot) yields a nearly straight line. The activation energy 
calculated from this slope is -1.3 Kcal/mole. Plots over 
the same temperature range for pH 5.4 E-FPLP, pH 9.2 E-FPLP, 
and pH 5.4 E-FPLP + malate result in activation energies of 
-1, 0.7, and -3.1 Kcal/mole respectively. 
A similar addition of L-glutamate at pH 5.4 resulted in 
an increase of the -32 ppm peak with a Kd of 4mm (Fig. 39, 
Fig. 40). The -20.7 peak comprized 35% of the total area at 
saturation with 10% of the coenzyme not bound (-8 ppm) and 
10% bound as E-FPMP (-36 ppm). The free enzyme (-20.7 ppm 
peak) decreases by about 50% when the temperature is raised 
from 5''C to 20'C. L-glutamate behaves in a similar manner 
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at pH 9.2 (Fig. 41 and Fig. 42). The Kd is about 0.8 mM. 
The -36.2 ppm peak broadens and shifts toward the -32 ppm 
peak. Although difficult to measure, the -36.2 ppm peak 
comprises about 10% of the total area at saturation. E-FPMP 
and the free coenzyme comprise about 4 and 6 % respectively. 
When malic acid was titrated at pH 5.4, a single peak 
was observed. This peak shifted upfield (downfrequency) 
with increasing amounts of malic acid. This peak reached a 
maximum width of 1450 Hz in Tris-acetate buffer. In Tris-
cacodylate buffer, the peak returned to -21 ppm over a one 
week period. This may be due to instability of malic acid 
in cacodylate buffer. 
When malic acid was titrated at pH 8.5, the peak at 
-35.4 ppm decreased and broadened as the peak at -26 ppm 
grew and sharpened. This is similar to the two peaks formed 
upon the addition of 2-oxoaspartate to E-FPLP at pH 5.4. 
The Km was 4 mm. At 128 mm malate, the -35.4 ppm peak 
contained about 50% of the area at 278°K. This decreased to 
about 10% at 298«K. 
The transverse relaxation time (Tg) for E-FPLP at pH 
5.4 with a linewidth of 310 Hz is 260 Hz. 
A narrow (8 Hz wide) peak was found to develop between 
-43.2 and -44 ppm when 5=FPLP was enzyme-bound. Under 
similar conditions, the resonance of 5 x 10"* M NaF was 
86 
-O 
1 I 1 I ' 
r 10 20 30 ,  40 50 
[2-METKYL ASPARTATE] (mM) 
Fluorine 19 NMR titration of E-FPLP with 
2-inethylaspartate at pH 5.4 
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20 
TEMPERATURE 
37. Variation with temperature of the NMR peak 
area of E-FPLP saturated with 2-methylaspartate 
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FIGURE 38. Variation with temperature of the NMR peak 
width for E-FPLP saturated with 
2-methylaspartate 
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E-FPLP • GLUTAMATE COMPLEX 
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30 E-FPLP 
20 
E-FPMP 
I V  
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. 20 - 40 
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FIGURE 39. Fluorine 19 NMR titration of E-FPLP with L-
glutamate, pH 5.4 
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Concentration of L-glutamate (bi;.;) 
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FIGURE 40. Fluorine 19 NMR spectra of E-FPLP titrated with 
L-glutamate at pH 5.4 
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FIGURE 41. Fluorine 19 NMR titration of E-FPLP with L-
glutatmae, pH 9.2 
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FIGURE 42. Fluorine 19 NMR spectra of E-FPOLP titrated with 
L-glutamate at pH 9.2 
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found at -44.03 ppm. When NaF was added to a sample of E-
FPLP with a peak at -43.76 ppm, a single peak at -43.79 ppm 
was obtained (Fig. 43). This indicates that F" is released 
from enzyme-bound 6-FPLP. The F" released can be dialyzed 
from the enzyme. 
Pyrrolopyridine Derivatives from Pyridoxal 5'-Sulfate 
Fluorescent products form at room temperature when 
pyridoxal 5'-sulfate is mixed with primary amines in large 
excess. The UV-visible spectrum is similar to that obtained 
from the lysine 258 modified by pyridoxal 5'-sulfate in AAT 
and isolated as described by Schmidt et al. (1982) (Fig. 5). 
The presence of these compounds was monitored by thin-layer 
chromatography (Table 8). The pyrrolopyridines have a 
brilliant blue-white fluorescence easily seen in solution as 
well as on TLC plates. The reaction is accompanied by 
relatively small changes in absorption spectrum; the 
increase in absorbance at 400 run can be used to indicate the 
extent of the reaction. However, at longer times the 
absorbance decreases again. The rate of reaction increases 
with increasing pH, but the product is less stable at higher 
pH. Maximal absorbance increases were obtained in the pH 
range 9.2-9.5. At pH 9.5, and room temperature the maximum 
was reached in about 7 h with 0.1 M n-propylamine and 2.6 x 
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FIGURE 43. Fluorine-19 NMR spectra of NaF. Bottom, 
released from 6-Fluoropyridoxal phosphate bound 
to apo aspartate aminotransferase. Middle, 5 x 
lOr* M NaF. Top, mixture of bottom and middle 
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10"pyridoxal sulfate. Raising the concentration of the 
pyridoxal sulfate did not lead to any further increase in 
yield, but the rate increased with increasing amine 
concentration up to at least 1 M. The reaction rate is 
linear at low concentrations of the reactants (Fig. 44 and 
Fig. 45). A concentration of 0.1 M amine represented a 
practical compromise between a maximum yield and an 
undesirably large excess of amine and of its hydrochloride. 
Methyl-, ethyl-, and n-butylamines, glycine, alanine, 
lysine, N-alpha-acetyllysine, and aspartic acid reacted in 
the same manner as did propylamine. The reaction with 
valine was much slower, and little reaction could be 
detected with ammonia under the same conditions. These 
chromophores contain a substituted 2H-pyrrolo[3,4-c]pyridine 
ring (Fig. 6). 
The numbering (Fig. 6) is that of the pyrrolopyridine 
(Patterson et al., 1960) with the more familiar numbering of 
pyridoxine given in parentheses. 
The fluorescent products were isolated by 
chromatography on an SP-Sephadex column at pH 3 followed by 
gel filtration on a column of Bio-Gel P-2. The absorption 
spectra of all resembled those of the product from 
propylamine and ethylamine (propyl and ethyl pyrrolopyridine 
Fig. 6). At all pH values (Fig. 46), these spectra are 
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TABLE 8. Rf values from thin layer chromatograms 
Compound R f® 
Modified lysine ( 3 ) from tripeptide 0.115 
Synthetic pyrrolopyridines from 
lysine 0.09, 0.125 
N-acetyllysine 0.31 
ethylamine ( 1 ) 0.38 
n-propylamine ( 2 ) 0.50 
glycine 0,31 
alanine 0.37 
cysteine 0.09 
^Solvent: acetic acid: l-butanol:water (1:4:1 v/v). 
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FIGURE 44. Reaction rate of 0.091 M alanine with pyridoxal 
sulfate 
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FIGURE 45. Reaction rate of 2,44 x lO'^M pyridoxal sulfate 
with alanine 
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closely similar to those of the peptides isolated from the 
pyridoxal sulfate modified aspartate aminotransferase and of 
the lysine chromophore (Fig. 6) obtained by degradation of 
the tripeptide (Fig. 5). From the pH dependence of the 
spectrum, pK values of -0.8, 6.3, and 11.3 have been 
estimated for the ethyl pyrrolopyridine (Fig. 6) from 20 
solutions ranging in pH from -1 to 12.2. The pK of 6.3 is 
almost identical with that of 6.4 found for the tripeptide 
(Schmidt et al., 1982) and nearly the same as that of 6.1 
reported by Yang et al. (1974) for the related chromophore 
from cysteine. The latter also had a high pK, estimated as 
12.25. The modified enzyme, presumably in denatured form, 
displayed a high pK of about 12.2 but the lack of isosbestic 
points did not permit estimation of a single pK 
corresponding to that of 6.3 in the lysine chromophore (Fig. 
6) (Yang et al., 1974). The calculated spectra of the 
individual ionic forms of ethyl pyrrolopyridine (Fig. 6) are 
given in Fig. 45. 
The proton NMR spectrum of the synthetic product ethyl 
pyrrolopyridine (Fig. 6) obtained from ethylamine is shown 
in Figure 47, and the *®C NMR spectrum is given in Table 9. 
An NMR titration curve is presented in Fig. 48. The low-pH 
spectrum (Fig. 47) shows that the 4(6)-H and 6'(2')-CH3 
resonances are fairly close to but somewhat shifted from the 
100 
12 
10 
8 CO 
6 
CD 
4 
2 
0, 20 28 32 36 40 
WAVE NUMBER cm^ «lO"^ 
I 1 1 1 L_ L_ 
500 450 400 350 300 250 
WAVELENGTH (nm) 
FIGURE 46. Spectra of four ionic forms of the 
2-ethylpyrrolopyridine (Fig. 6) 
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expected positions for ordinary 3-hydroxypyridines. These 
are 8.74 and 2.49 for ethyl pyrrolopyridine (Fig. 6) and 
8.32 and 2.75 ppm, respectively, for the cation of 
pyridoxamine (Korytnyk and Ahrens, 1970). The beta-methyl 
and alpha-methylene resonances of the ethyl group are 
present as expected at 1.61 ppm (triplet, J = 7.32 Hz) and 
4.45 ppm (quartet), respectively. In addition, there are 
two exchangeable protons at 8.1 and 7.6 ppm in the aromatic 
region. We identify these with the 1(4') and 3(5') protons 
respectively of the pyrrolopyridine ring of the proposed 
structure. The peak at 7.6 ppm exchanges out rapidly at low 
pH and was stable only when the spectrum was recorded in 
water (Fig. 47). In deuterium oxide, it disappeared at low 
pH with a half-time of about 1 h at pH 0-1. The 8.1 ppm 
peak disappeared more slowly, the half-time being about 4.5 
h at pH 0-1. At pH 6.5, both protons exchanged out with a 
half-time of about 7 h. 
The carbon-13 NMR spectrum (Table 9) shows the presence 
of the expected 10 carbon atoms. Two of these, at 110.3 and 
120.2 ppm, were not observed in deuterium oxide after the 
exchangeable protons had been removed. This identifies them 
as C-1 and C-3. The ethyl carbons are easily assigned. The 
other aromatic carbons were assigned tentatively by 
comparison of their positions to those in pyridoxine. 
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CHEMICAL SHIFT, ppm from TMS 
FIGURE 47. 90 MHz proton NMR spectrum of the ethyl 
pyrrolopyridine (Fig. 6) illustrating the 
exchange of the 1 and 3 protons 
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TABLE 9. Carbon-13 chemical shifts of ethyl pyrrolopyridine 
(Fig, 6) 
Chemical shifts, ppm relative to IMS Assignment^ 
a 
for 1 for pyridoxine® 
11.7 CH3 of ethyl group 
15.7 13.6 6'(2')-CH3 
46.8 CH2 of ethyl group 
110.3 56.2 1(4') or 3(5') 
117.3 129.2 4(6) 
118.1 136.2 3a(5) _d 
118.2 139.9 7a(4) 
120.2 57.4 1(4') or 3(5') 
132.3 142.1 6(2) 
-d 
143.1 152.1 7(3) 
^The spectrum was obtained at pD on 55 umol ot sample. 
^The numbering is that of the pyrrolopyridine ring with the 
numbering of the pyridine ring as used for vitamin B5 derivatives 
in parentheses. C-1 and C-3 were identified by their loss of 
intensity when the attached protons exchanged out. 
^Obtained on the Bruker WM-300 spectrometer at pH 2.6. These 
values are in satisfactory agreement with those published by 
Mantsch and Smith (1979). 
'^Tentative assignments based on comparison with those of 
pyridoxine. 
104 
oO 
Ë 7.7 
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pH METER READING 
FIGURE 48. NMR titration curve for the ethyl 
pyrrolopyridine (Fig. 6). Upper curve, 4(6). 
Middle curve, 3(5'). Lower curve, 1(4') 
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The NMR titration curve of Fig. 48 is in good agreement 
with that obtained from the UV visible spectra. The solid 
lines drawn in Fig. 48 are based on "pK" values of -0.4, 
6.35, and 11.9. The first two of these values agree well 
with the spectrophotometrie values of -0.8 and 6.3 while 
there is some discrepancy between the upper values of 11.9 
and 11.3 estimated by the two methods. Note, however, that 
the pKs from the NMR titration are based on pH meter 
readings in deuterium oxide and not on pD. 
The mass spectrum of ethyl pyrrolopyridine (Fig. 6) 
contains a strong peak at m/e 176, the expected parent 
position. The exact mass was measured as 176.09485 
(calculated for CIOHIZNEO, 176.09497). When a sample of 
ethyl pyrrolopyridine (Fig. 6) in which the 1 and 3 protons 
had been completely replaced by deuterium as judged by NMR 
was subjected to mass spectrometry by using an ordinary 
capillary sample tube, very little of the expected peak at 
mass 178 was observed. To clarify this finding, we enlisted 
the aid of Drs. A Bencsath and F. H. Field at the 
Rockefeller University Mass Spectrometric Biotechnology 
Research Resource. They used a ceramic direct insertion tip 
and desorption chemical ionization (Bencsath and Field, 
1981). With this technique, the expected ions of (M + l)"*" + 
179 for the dideuterated compound were observed clearly. 
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However, the 179 peak dropped rapidly; the 178 peak then 
rose and fell to yield a 177 peak. Thus, rapid exchange of 
the 1 and 3 protons occurs in the mass spectrometer. 
Besides the parent ion peak at 176 additional peaks at 
164 and 147 were present as well as at 192 and 206. These 
heavier peaks had exact masses of 192.090120 (192.08988 
calculated for CioHioNgOg) and 206.06943 (206.06914 
calculated for C10H10N2O3) Apparently, ethyl pyrrolopyridine 
(Fig. 6) also reacts in the mass spectrometer with oxygen. 
Two hydrogen atoms must be lost to give the mass 206 peak. 
The fact that there is almost no 209 peak and mostly the (M 
+ 1)+ = 207 peak in the chemical ionization spectra suggests 
that it is the 1 and 3 protons that are lost. 
The pyrrolopyridine formed with aspartate (Fig. 6) was 
stable and less soluble between pH 2.5 and pH 4. Crystals 
suitable for X-ray analysis have been grown, diffraction 
data has been collected by R. Jacobson, and analysis begun 
by R. Honzatko. 
Ethyl pyrrolopyridine (Fig. 6) is converted by reaction 
with acetic anhydride to an 0-acetyl derivative whose mass 
spectrum has the expected parent ion peak at m/e 218, as 
well as additional peaks at 147, 164, 176 (parent ion of 
ethyl pyrrolopyridine. Fig. 6), 192, 206, 234, and 250. The 
absorption spectrum of the acetylated compound closely 
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resembles that of ethyl pyrrolopyridine (Fig. 6) at low pH, 
having a peak position of 385 nm and a spike at 284 nm as 
does ethyl pyrrolopyridine itself. However, at pH 8 the 
absorption maximum is at 345 nm rather than at 400 nm as for 
ethyl pyrrolopyridine (Fig. 6). An apparent pK of about 7.2 
was estimated. The acetylated compound migrated as a single 
spot of Rf = 0.2 and had a green fluorescence in the system 
acetic acid-l-butanol-water (1:4:1 v/v). Unmodified ethyl 
pyrrolopyridine (Fig. 6) had an Rf of 0.3 and a blue-white 
fluorescence. 
The pyrrolopyridines are reasonably stable in acid but 
at high pH decompose rapidly. The characteristic absorption 
at 350 nm disappears in an approximately first-order 
process. At pH 7.5, the half-time is about 19 h whereas at 
pH 12 it is only 22 min. Preliminary examination of the pH 
profile suggests that the dipolar ionic species present at 
neutral pH decomposes spontaneously at a slow rate and that 
at higher pH the same form is attacked by OH", the rate 
becoming relatively constant above the pK of 11.3. The 
absorption spectrum after the base-induced decomposition has 
occurred is broad (Schmidt et al., 1982) and is 
significantly different at pH 12 than at pH 10. 
From a sample of ethyl pyrrolopyridine (Fig. 6) allowed 
to stand at pH 12.2 for 15 h and chromatographed on Bio-Gel 
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P-2 in 0.01 M formic acid, two or three major compounds and 
five to six minor products were separated. The relative 
amounts of the products vary with pH. The electronic and 
proton NMR spectra of the first of these compounds 
(3-hydroxy derivative. Fig. 49) shows that it contains an 
intact 3-hydroxypyridine ring and probably arose by attack 
of OH' on the pyrrole ring of ethyl pyrrolopyridine (Fig. 
5). The NMR resonances at pH 3 in ppm are as follows; 
4(6)-H, 8.32; 6(2)-CH3, 2.66; -CH3 of the ethyl group, 
quartet, centered at 3.69, J = 7.3; CH3 of the ethyl group, 
triplet, 1.30. In addition a two proton singlet at 4.4 ppm, 
probably representing the I-CH2 group, and a weak singlet at 
4.4 ppm, possibly a partially exchanged 3-H, were found. 
The positions of the ethyl group resonances are distinctly 
shifted upfield from their positions in ethyl 
pyrrolopyridine (Fig. 6) by 0.73 (CHg, and 0.27 ppm (CH3) 
The absorption maximum was at 289, 317, and 312 nm at low, 
neutral, and high pH, respectively, with pK values of about 
4.0 and 7.5. The probable structure is a 1,3-hydrate(3-OH) 
derivative (Fig. 49) of ethyl pyrrolopyridine (Fig. 6). 
Both the electronic and NMR spectra of a 4-keto 
derivative (Fig. 49) produced by basic degradation of ethyl 
pyrrolopyridine (Fig. 6) show that the 3-hydroxypyridine 
ring has been destroyed. The absorption maximum at 290 nm 
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at pH 6 is shifted to 285 nm at pH 12. The ring CHg 
resonance is still present in the NMR spectrum at pH 4 but 
has been shifted upfield (downfreguency) to 1.64 ppm. 
However, the resonances of the ethyl group are close to the 
same positions as in ethyl pyrrolopyridine (Fig. 6). Two 
single proton doublets at 7.50 and 7,72 ppm are coupled with 
J = 1.98 Hz and presumably represent the 1 and 3 protons. 
The positions suggest that the pyrrole ring remains intact 
in this product and that the attack by hydroxide ion has 
occured in the pyridine ring. The molecular formula of 
C10H10N2O2 is indicated by an exact mass of 190.07430 and 
suggests that the structure is a 4-keto derivative (Fig. 
49). An exact mass of 209.09174 (molecular foumula 
C10H13N2O3), suggests hydration across the 4-5 bond. 
Reaction of 2 x 10"^ M ethyl pyrrolopyridine (Fig. 6) 
and 3 x 10"* M periodic acid at pH 3 destroyed the 382 nm 
band with formation of a new band at 312 nm. The reaction 
was half complete in 15 min. After 14 h, the sample was 
concentrated to a small volumn and chromatographed on a 
column of Bio-Gel P-2 with 0,01 M formic acid. Three major 
products were separated. The first appears from the 
absorption spectra to be a 3-hydroxypyridine while the other 
two have broad absorption bands at 294 and 308 nm, 
respectively. 
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1,2-hydrate(3-0H), 2-ethylpyrrolopyridine derivative 
1,3-reduced, 2-ethylpyrrolopyridine derivative 
5-keto, 2-ethylpyrrolopyridine derivative 
FIGURE 49. Structures of products derived from 2-ethyl, 
5-inethyl, 7-hydroxy pyrrolo[3,4-c]pyridine (Fig. 
6) 
Ill 
As with the products formed from cysteine and from apo-
aspartate aminotransferase (Yang et al., 1974), ethyl 
pyrrolopyridine (Fig. 6) is resistant to reduction by sodium 
borohydride. However, when solid borohydride was added 
gradually at pH 8.4 with frequent adjustment of the pH with 
formic acid, the absorption at 397 nm decreased slowly over 
a period of hours and finally disappeared. Passage of the 
resulting solution through a column of Bio-Gel P-2 separated 
two to three major bands. The first of these had an 
absorption spectrum typical of a substituted 
3-hydroxypyridine with absorption maxima at 286, 315, and 
294 nm, respectively, for low, neutral, and high pH. 
Apparent pK values were 3.2 and 9.0. These peak positions 
are similar to those of the hemiacetal form of isopyridoxal: 
283, 311, and 295 nm at low, neutral, and high pH. The NMR 
spectrum in neutral solution had the expected 4(6)-H 
resonance at 7.6 ppm and the 6(2)-CH3 resonance at 2.45 ppm. 
The ethyl group resonances were as follows: CHg, 1.3 ppm, J 
= 7.3 Hz; CHg, 3.2 ppm. The latter is shifted from the 
position in ethyl pyrrolopyridine (Fig. 6) (4.15 ppm) even 
more than in the base decomposition product 3-hydroxy 
derivative (Fig. 49). In addition, two resonances each 
containing two protons are present at 4.37 and 4.44 ppm. 
This suggests the formation of a reduced derivative of ethyl 
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pyrrolopyridine (Fig. 49). The other products have not been 
characterized but appear to include one or more of the 
products of base catalyzed decomposition. 
The 5'-trans-carboxyethenyl analogue of pyridoxal 
phosphate reacts with apo-aspartate aminotransferase to give 
a product resembling that obtained with pyridoxal 5'-sulfate 
(Miura and Metzler, 1976). Fluorescent peptic digestion 
products resemble those obtained with pyridoxal sulfate 
(Schmidt et al., 1982). We were also able to show that this 
compound reacts with various amines to form fluorescent 
products analogous to those obtained from pyridoxal sulfate. 
The reactions took place best at pH 9 and room temperature. 
Thin-layer chromatography gave spots of the Rf values given 
in Table 8. Proton NMR resonances of the product with 
ethylamine are assigned as follows: 4(6), 8.73 ppm; 1(4'), 
7.61 ppm ; 2', 4.37 ppm (J=7.35); 3*(5"), 2.70ppm; 6(2), 
2.48ppm; 2", l.Slppm (J=7.35). The 1(4') proton was of low 
intensity at pH 1.2 and exchanged out after 1 h. The 
structure is indicated in Fig. 50 
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FIGURE 50. Structure of the pyrrolopyridine formed in the 
reaction of the 5'-trans-carboxyethyenyl analog 
with lysine 
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DISCUSSION 
The major electronic effect of the fluorine in 6-FPLP 
is a lowering of the pK of the ring nitrogen by more than 
4.6 pH units (3.6 to < -1). The microscopic pK of the 
phenolic group is almost the same in both 6-FPLP and 6-FPMP 
(Table 1). The lowering of the pK of the pyridinium group 
by 6-fluoro substitution without an effect on the pK of the 
phenolic group is in accord with the known electronic 
properties of fluorine on an aromatic ring derived from 
Hammett relationships (Hammett, 1970; Sanchez-Ruiz et al., 
1984; Barlin and Perrin, 1966, and Jaffe', 1955). 
The carbonyl group of PLP is highly hydrated at low pH, 
less so at neutral pH, and much less at high pH (Ahrens et 
al., 1970; Harris et al., 1976). This change in degree of 
hydration presumably reflects increasing donation of 
electrons from the phenolic oxygen into the carbonyl group, 
an interaction that should inhibit hydration. Hydration of 
the carbonyl group of 6-FPLP and its Schiff base with valine 
is increased from that of the non-fluorinated compounds 
(Table 2). This is probably due to electron withdrawal by 
the fluorine which counteracts the electron donation of the 
phenolic oxygen into the carbonyl group, an effect expected 
to inhibit hydration. 
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Both 6-FPLP and 6-FPMP have a strong tendency to exist 
in non-dipolar ionic forms below their pKs of 7.8 and 7.45. 
These pK values are those of the phenolic group (see also 
Chang and Graves, 1985). The anion, neutral, dipolar ion, 
and cation of pyidoxine absorb at 309, 285, 324, and 291 nm 
respectively. Peak positions of 290, 321, and 317 nm 
correspond to the anion, neutral, and cation of 6-FPMP. 
AAT is able to stabilize the dipolar ionic form of both 
6-FPLP above the pK of 7.1 and 6-FPMP below the pK of 8.2. 
No significant effect of dissociation of the phosphate 
group, whose pK is about 6.2, is seen. The ability of AAT 
to control charge in the active site makes it possible to 
use the fluorinated coenzyme with retention of high 
catalytic activity. The pK of the pyridinium nitrogen in 
native AAT is > 9, thus lowering the pK of the ring nitrogen 
in 6-FPLP by 4.6 pH units from that of PLP (Table 4) results 
in a predicted pK on the enzyme of > 4.4. This is over 5 pH 
units higher than the pK of free 6-FPLP. The ability of the 
enzyme to protonate this nitrogen is due to either aspartate 
222 having a low pK due to a buried positive charge on a 
cluster of three histidines, or the pK of the nitrogen may 
be raised from a stronger interaction with the 3-OH group of 
the coenzyme in the low dielectric surroundings of the 
active site. Similar considerations apply to bound 6-FPMP. 
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The microscopic constant for the ring nitrogen when the 
phenolic group is deprotonated might be 4.6 units below the 
value of 8.5 observed for PMP. However, the ring nitrogen 
does remain protonated in the enzyme at pH 5. This suggests 
that the pK of aspartate 222 may be unusually low. The 
appearance of a pK of 8.2 with a shift of the absorption 
band to lower wavelengths suggests strongly that the ring 
nitrogen becomes deprotonated at high pH. This is in 
agreement with the conclusion that the microscopic pK of the 
protonated ring nitrogen should be lower for bound 6-FPMP 
than for bound 5-FPLP. 
Changes in chemical shift of enzyme bound 6-FPLP upon 
binding due to solvent interactions or ring currents should 
be small for Fluorine chemical shifts are primarily 
responsive to inductive effects of substituents in a ring. 
The chemical shifts can be predicted semiquantitatively from 
the shifts for monosubstituted fluorobenzenes (Gutowsky et 
al., 1952; Table 3) which are almost additive. Thus, the 
predicted chemical shift for 5-deoxy-6-FPMP is -8.2 (F-
benzene) -0.9 (2-CH3) -10.6 (3-OH) -0.6 (4-CH2NH2+) -5 
(5-CH3) + 41.3 (ring N) = -14 ppm. This is reasonably close 
to the observed value of -8.2 ppm for 6-FPMP at low pH. The 
shift of -10.7 ppm to lower frequency (upfield) for 
dissociation of the phenolic group of 6-FPMP is close to the 
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shift of -10.6 ppm for dissociation of 4-F-phenol (Gutowsky 
et al., 1952). Data on chemical shifts when an adjacent 
ring nitrogen is protonated are not available from the 
literature. The titration curve for 6-F-pyridoxine (Fig. 
31) put this shift at +14 ppm. Studies with F-PLP analogs 
3-fluorophenol and 2-fluoropyridine (Fig. 24, Table 3) 
indicate that deprotonation of the 3-OH group shifts the ^'F 
NMR resonance 10 ppm upfield while protonation of the 
pyridinium nitrogen results in a 14 ppm upfield shift. The 
^'F NMR chemical shift of 6-FPMP and 6-FPLP can therefore be 
used to monitor the state of protonation of the ring (Chang, 
1984; Scott et al., 1985). 
Protonation of the ring nitrogen leads to shifts to 
higher frequency for the adjacent 6-H nucleus. Proton 
chemical shifts are directly related to electron density 
(diamagnetic). The ^'F chemical shifts are dominated by 
valency p electrons which depart from spherical symmetry 
(paramagnetic) (Emsley et al., 1965). The large opposite 
shift for the 6-F nucleus is probably due to interactions of 
the lone pair of electrons of the ring with the fluorine. 
Fluorine chemical shifts are large due to paramagnetic 
interactions (Emsley et al., 1966). Long range interactions 
need to be taken into account to explain the chemical shift 
of fluorine ortho to another fluorine on an aromatic ring 
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(Dewar and Kelemem, 1968). These interactions are dependent 
upon the charge density on the adjacent atom divided by the 
cube of the distance between the two atoms. The n-pi* 
transition of the pyridinium nitrogen is of lower energy 
when it is deprotonated. This removes electron density from 
the pi system of the aromatic ring when the nitrogen is 
protonated. The electron density is then more centered 
around the nitrogen and shifts the ^ NMR resonance 100 ppm 
downfreguency (Levy and Lichter, 1979). The increased 
electron density on the nitrogen also acts to shield the 
fluorine and shift it downfreguency (upfield). This may 
occur either through bonds or through space and would tend 
to move the resonance upfrequency (downfield). The 
increased electrostatic repulsion of the protonated 
pyridinium nitrogen with the fluorine may lower the pK of 
this group. 
The chemical shift of bound 6-FPMP at high pH is -22.1 
ppm, only 3,2 ppm more negative than for the free anionic 
coenzyme. Likewise, at low pH the -35.3 ppm chemical shift 
is only 3.7 ppm more negative than that predicted for the 
dipolar ion. Similarly, bound 6-FPLP above the pK has an 
chemical shift of -36.2 ppm, 5.4 ppm more negative than 
is predicted by adding -14 to the chemical shift for the 
anion of the Schiff base with valine (Table 3). Although 
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there is an additional shift of -3.2 to -5.4 ppm for binding 
to the protein, these results appear to confirm the 
conclusion based on the electronic spectra that bound 6-FPMP 
has a dipolar ionic ring below its pK and that the Schiff 
base of 6-FPLP exists as a dipolar ion below its pK. 
The amount of the enolimine tautomer (Fig. 7) formed in 
the Schiff base with valine is 4 times greater (7% to 25%) 
with 6-FPLP than with PLP (Fig. 9, bottom panel and Fig. 15 
(top panel) (Metzler et al., 1980). Electron withdrawal by 
the fluorine lowers the pK of the imine nitrogen and allows 
the proton to shift to the phenolic oxygen. For 6-H 
containing Schiff bases the intensity of light absorption of 
the enolimine tautomer (Fig. 7) is about 60% that of the 
ketoenamine. For the Schiff base of 6-FPLP + valine it is 
about 78% as great (Table 3). The tautomeric ratio can be 
shifted by solvent (Table 7). The sum of the areas of the 
ketoenamine + enolimine/0.788 for various water methanol 
mixtures is nearly constant (Table 3). When this is plotted 
versus the shift of the single ^'F NMR resonance (Fig. 15, 
top panel) a nearly linear relationship is obtained. 
Extrapolation places the shift of enolimine and ketoenamine 
(Fig. 7) at -14.7 and -21.8 ppm respectively. This change 
(7.1 ppm) is the same for the de-protonation of 
4-fluorophenol (7.1 ppm). Protonation of 
3-fluorobenzylamine has a small effect (Fig. 25). 
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For the native enzyme the results of X-ray 
crystallography (Arnone et al., 1985, Ford et al., 1980; 
Jansonius et al., 1985) and of Resonance Raman Spectroscopy 
(Benecky et al., 1985; Kallen et al., 1985) make it clear 
that in the low pH ketoenamine form the pyridine ring in the 
aspartate aminotransferases is protonated on the ring 
nitrogen. The state of protonation of E-FPLP at low pH is 
less certain. X-ray diffraction measurements by Arnone et 
al. (1985) show that in the crystalline enzyme 6-FPLP is 
bound in the same place and with the same orientation as in 
PLP in the native enzyme. Protonation of the 3-OH in the 
predominant enolimine tautomer will decrease the pK of the 
ring nitrogen from its already low value by 3 units or more. 
This could allow the proton to move from the ring nitrogen 
onto the carboxylate of Asparate 222. The 
[ketoenamine]/[enolimine] tautomeric ratio can be varied in 
the enzvme bv addition of dicarboxvlates fFia. 19. Table 6\. 
• - - - ^ ^ » •» • * 
When the % ketoenamine is plotted versus the ^'F chemical 
shift, a linear relationship is obtained (Fig. 15, bottom 
panel) which spans 20.8 ppm. This is 13.6 ppm greater than 
that obtained with 6-FPLP and valine (Fig. 15, top panel). 
Since the shift obtained upon protonation of the ring 
nitrogen is about 14 ppm (Fig. 31, Table 4), this indicates 
that the pyridinium nitrogen is protonated in the 
ketoenamine tautomer but not in the enolimine (Fig. 7). 
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Binding of the dicarboxylate 'substrate analogs' favors 
the ketoenamine tautomer and therefore increases electron 
density at the pyridinium nitrogen. With 6-FPLP, this 
results in protonation of the pyridinium nitrogen. In the 
native enzyme, the pyridinium nitrogen is probably always 
protonated but the increased electron density could weaken 
the electrostatic interaction with Asp 222 and allow the 
ring to rotate. The NMR data indicate that the proton is 
bound to the ring nitrogen most tightly in the 'external 
aldimine' of the 2-methylaspartate complex. From the 
electronic spectra, we estimated the tautomeric ratio as 
0.46 (Fig. 31). Due to the overlapping of bands (Table 3), 
this value is uncertain. From the ^'F chemical shifts, it 
would have to be 0.25 to lie on the least square line in 
Fig. 31. This ratio would indicate that the hydrogen bonded 
interaction between aspartate 222 and the protonated ring 
nitrogen will be weaker in the 2-methylasparate complex than 
in the free enzyme at low pH or with other dicarboxylates. 
This may allow for easy tilting of the coenzyme ring during 
catalysis. 
The rate of a process can often be obtained from NMR 
measurements. The appearance of two peaks in an NMR 
titration can be used to calculate the fastest exchange rate 
possible (Sandstrom, 1982). 
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pi * frequency difference of the peaks 
exchange rate = 
21/2 
A faster exchange rate would average the two peaks into one 
peak. The fastest exchange rate possible is presented in 
table 10 for AAT under various conditions. The exchange 
rate for malic acid is calculated to be 3KHz from peak 
broadening (Sandstrom, 1982). The maximum velocity for the 
native enzyme is 1000 s"^ at 25*C. The maximum velocity at 
S'C is expected to be about one fourth the rate at 25"C. 
The upper limit for the diffusion of L-glu at pH 8.3 is 2500 
sec'i (Table 10). If the 6-fluoro substitution doesn't 
affect substrate binding, the process of substrate diffusing 
through the active site pocket to the active site at the 
bottom of the pocket may occur during 10% or more of the 
catalytic cycle. The presence of a peak at the position of 
free E-FPLP when saturated with either 2-methylaspartate 
(Fig. 36) or L-glutamate (Fig. 39) which decrease with 
increasing temperature (Fig, 37) may be related to the 
movement of substrates through the active site pocket. For 
saturated L-glutamate, 35% is free, which would correspond 
to a diffusion rate of 750 sec'i at 5''C or 35% of the 
catalytic cycle. 
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Although the imine proton is tightly held, it moves 
rapidly between the 3'-hydroxyl and imine nitrogen. 
Lowering the temperature of a solution of 5-FPLP and valine 
in 70% methanol to 210'K did not resolve the single NMR peak 
into one for each tautomer. 
At low pH, the ring nitrogen of E-FPMP is protonated. 
Above the pK of 8.2, both UV-visible and NMR spectra 
indicate that this nitrogen is deprotonated. Addition of 
glutarate (Fig. 22) or raising the temperature (Fig. 23) 
also protonates the ring nitrogen. Thus, as with the 6-FPLP 
form, binding of a substrate analog increases electron 
density on the ring nitrogen. This could be related to 
movement of the small domain. 
Measurement of the linewidth of a resonance at 
different field strengths can be used to partition the 
linewidth into dipolar and chemical shift anisotropy 
contributions (Hull and Sykes, 1975). The variation in 
linewidth as a function of field strength (Fig. 29) for the 
E-FPMP and E-FPMP + glutamate indicates that the intercept 
(dipolar relaxation) remains the same but the slope 
indicates more chemical shift anisotropy (movement) for 
glutamate. Similar slope but varying intercept when the 
ionic strength is changed at pH 5.4 indicates a large change 
in the dipolar relaxation mechanism. This change may be due 
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TABLE 10. Rate constants determined by NMR 
Peak Maximum 
Separation (Hz) Broadening (Hz) Rate (s~ ) 
E-FPLP + 2-methyl aspartate 2767 <6,150 
E-FPLP + L-glutamate, pH 5.4 3247 < 7,200 
E-FPLP + L-glutatmae, pH 9.2 1163 ft 2,600 
E-FPMP pK 3671 <8,200 
E-FPLP pK 4377 <9,700 
E-FPLP pK 850 800 
E-FPLP + malic acid, pH 5.4 1,600 3,000 
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to the binding of anions to arginine 292. Arginine 292 is 
close to the fluorine. 
The release of F" from E-FPLP is enzyme catalyzed. The 
-43 ppm peak increases with time and was not observed in 
solutions of either 6-FPLP of 6-FPLP bound to glycogen 
phosphorylase (Chang and Graves, 1985). The slow rate of 
formation (0.5% of the total area in 6 weeks, 20mm Tris-
acetate, pH 5.4) appears to increase when substrates are 
added. The shift in peak position of NaF by E-FPLP (Fig. 
43) is probably due to a rapid exchange process of F" 
binding to AAT. When dialyzed from AAT, the enzyme produced 
resonance is at -44 ppm. Fluoride could be released by 
first adding a proton at the 6 position using electrons 
donated by the 3-hydroxyl. The fluorine could then be 
eliminated together with the 4' proton. This would result 
in a more oxidized ring form. 
Support for the proposed pyrrolopyridine structure of 
the product of pyridoxal 5'-sulfate with ethylamine is 
obtained from the positions of the resonances of both ^ 
and NMR. A reasonable mechanism (Fig. 4) exists which is 
supported by the release of sulfate synchronously with the 
formation of the pyrrolopyridine (Yang et al., 1974) and the 
first order kinetics of both reactants (Fig. 44 and Fig. 
45). The unusual and characteristic absorption spectra 
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(Fig. 45) and NMR spectra (Fig. 48) resemble those of 
2-methyl-2H-pyrrolo[3,4-c]pyridine reported by Armarego et 
al. (1972). This includes the presence of 2 exchangeable 
protons in nearly the same positions. 
The absorption bands in the UV-visible spectrum are 
narrow, suggesting that a single predominant pathway for 
dissociation does exist. A possible assignment of the 
observed pK values of -0.8, 6.3, and 11.3 to the structures 
in Fig. 51 is suggested. The pK of 11.3 represents the 
proton on the pyridinium nitrogen. The increase over the pK 
of 8.57 reported by Armarego et al. (1972) is probably due 
to the delocalized negative charge of the phenolate ion. 
Similar effects are seen in simple 3-hydroxypyridines 
(Metzler et al., 1973). The pK of 6.3 is that of the 
phenolic group. The bathochromic shift of 1500 cm"^ in the 
low energy UV-visible absorption maximum upon dissociation 
is less than the 3300 cm"* cm found by Metzler et al. 
(1973). The pK is also higher than that of 3.3-5 observed 
for 3-hydroxypyridines. These differences are attributed to 
the lowered donation of electrons from the phenolate ion 
into the ring system due to the pyrrole nitrogen. The low 
basicity of pyrroles makes it likely that this ring is the 
last to be protonated. 
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HO HO. 
H 
HO 
H 
FIGURE 51. Dissociation scheme for ethyl pyrrolopyridine 
(Fig. 6) 
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Lyophi1ization seems to cause some decomposition of the 
pyrrolopyridines. The valley in the UV-visible spectrum 
increases in absorbance. This may be due to oxidation by 
oxygen since a M+18 peak is observed in the mass spectra of 
ethyl pyrrolopyridine (Fig. 6). 
The phosphate group of PLP bound to AAT is not in an 
extended conformation (Fig. 2) but in a conformation that 
places the 5"-0 near the 4'-0. It is possible that this is 
the reason pyridoxal sulfate reacts in AAT to form a 
pyrrolopyridine; however, the active site of the 
mitochondrial isozyme is similar and showed no reactivity in 
a preliminary experiment. There may, therefore, be some 
further stereoelectronic control of this reaction which 
favors its occurrence in AAT. 
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CONCLUSION 
The chemical and spectroscopic properties of 
6-fluoropyridoxal 5'-phosphate, of its Schiff base with 
valine and of 6-fluoropyridoxamine 5'-phosphate have been 
investigated. The modified coenzymes have also been 
combined with the apo form of cytosolic aspartate 
aminotransferase and the properties of the resulting enzymes 
and of their complexes with substrates and inhibitors have 
been recorded. Although the presence of the 6-fluoro 
substituent reduces the basicity of the ring nitrogen over 
10,000 fold, the modified coenzymes bind predominantly in 
their dipolar ionic forms as do the natural coenzymes. 
Enzyme containing the modified coenzymes binds substrates 
and dicarboxylate substrates normally, and has about 42% of 
the catalytic activity of the native enzyme. Fluorine-19 
NMR measurements show that the ring nitrogen of bound 
6-fluoropyridoxamine phosphate is protonated at pH 7 or 
below but becomes deprotonated at high pH around a pK of 
8.2. The bound 6-fluoropyridoxal phosphate, which exists as 
a Schiff base with a dipolar ionic ring at high pH becomes 
protonated with a pK of 7.1, corresponding to the pK of 6.4 
in the native enzyme. Below this pKa, a single ^ *F 
resonance is seen corresponding to ketoenamine and enolimine 
tautomers of the Schiff base. The tautomeric ratio and 
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chemical shift are altered upon binding of dicarboxylate 
inhibitors indicating that during the rapid tautomerization 
a proton is synchronously moved from the ring nitrogen (in 
the ketoenamine tautomer) onto the aspartate 222 carboxylate 
(in the enolimine tautomer). The deprotonation is 
synchronous with the protonation of the 4'-phenolate ion. 
6-FPLP can be used to monitor the state of protonation of 
the coenzyme. The lowered pK of the pyridinium nitrogen 
allows for protonation/deprotonation of this group in both 
the 5-FPMP and 6-FPLP forms of the enzyme. Binding of 
substrates favors protonation in both forms. More 
information concerning the dynamics of interactions with 
this enzyme may be obtained. This coenzyme analog may be 
useful in differentiating the active sites of many vitamin 
B-6 dependent enzymes according to the protonation state of 
the ring nitrogen. 
A fluorescent derivative of lysine 258 isolated from 
the active site of aspartate aminotransferase modified by 
treatment of the apoenzyme with pyridoxal 5'-sulfate has 
been characterized as a substituted 2H-
pyrrolo[3,4-c]-pyridine. Similar pyrrolopyridines are 
produced in up to 20% yield by reaction of pyridoxal sulfate 
with simple alkylamines or with amino acids. The reaction 
with lysine forms two products, one of which is identical to 
131 
the isolated chromophore. The pyrrolopyridine derived from 
ethylamine has been characterized by and ^NMR, UV-
visible, and mass spectroscopy. Pyridoxal 5'-sulfate 
provides a practical synthetic route to a family of new 
pyrrolopyridines. Pyridoxal sulfate is readily made from 
pyridoxine hydrochloride in a three step synthesis with 32% 
yield (Yang et al., 1974). Ethyl pyrrolopyridine and the 
lysine chromophore (Fig. 6) have been obtained in 20% yield. 
Fluorescent derivatives of a wide variety of amines and 
amino acids can be made this way. The derivative with 
aspartate has been crystallized and the structure solved by 
crystallographic analysis. The biological significance is 
undetermined. No formation of pyrrolopyridines from 
pyridoxal 5'-phosphate has been observed but it could be 
catalyzed enzymatically or photochemically. Thus, the 
occurrence of these compounds among the fluorescent 
substances found in organisms is a possibility. They could 
be part of the normal catabolic reactions of pyridoxal 
phosphate. 
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